References

123

Reference List

1. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatorydrug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group, Cephalalgia, 19 (1999) 232-240.

2. Ad hoc committee on the classification of headache of the national institute of neurologicaldiseases and blindness, NIH., Classification of headache, JAMA, 179 (1962) 717-718.

3. Alvarez, F.J. and Priestley, J.V., Anatomy of somatostatin-immunoreactive fibres and cell bodiesin the rat trigeminal subnucleus caudalis, Neuroscience, 38 (1990a) 343-357.

4. Alvarez, F.J. and Priestley, J.V., Ultrastructure of somatostatin-immunoreactive nerve terminals inlaminae I and II of the rat trigeminal subnucleus caudalis, Neuroscience, 38 (1990b) 359-371.

5. Alvarez, W.C., Notes on the history of migraine, Headache, 2 (1963) 209-213.6. Amano, N., Hu, J.W. and Sessle, B.J., Responses of neurons in feline trigeminal subnucleus

caudalis (medullary dorsal horn) to cutaneous, intraoral, and muscle afferent stimuli,J.Neurophysiol., 55 (1986) 227-243.

7. Amery, W.K. and Vandenbergh, V., What can precipitating factors teach us about thepathogenesis of migraine?, Headache, 27 (1987) 146-150.

8. Andersson, J.L., Muhr, C., Lilja, A., Valind, S., Lundberg, P.O. and Langstrom, B., Regionalcerebral blood flow and oxygen metabolism during migraine with and without aura, Cephalalgia,17 (1997) 570-579.

9. Andres, K.H., von During, M., Muszynski, K. and Schmidt, R.F., Nerve fibres and their terminals ofthe dura mater encephali of the rat, Anat.Embryol.Berl., 175 (1987) 289-301.

10. Anthony, M. and Hinterberger, H., Amine turnover in migraine, Proc.Aust.Assoc.Neurol., 12(1975) 43-47.

11. Anthony, M. and Lance, J.W., Histamine and serotonin in cluster headache, Arch.Neurol., 25(1971) 225-231.

12. Anton, F., Herdegen, T., Peppel, P. and Leah, J.D., c-FOS-like immunoreactivity in rat brainstemneurons following noxious chemical stimulation of the nasal mucosa, Neuroscience, 41 (1991)629-641.

13. Arbab, M.A., Delgado, T., Wiklund, L. and Svendgaard, N.A., Brain stem terminations of thetrigeminal and upper spinal ganglia innervation of the cerebrovascular system: WGA-HRPtransganglionic study, J.Cereb.Blood Flow Metab., 8 (1988) 54-63.

14. Argiolas, A. and Melis, M.R., The neuropharmacology of yawning, Eur.J.Pharmacol., 343 (1998)1-16.

15. Aubineau, P. and Delepine, L., Electrical stimulation of the sphenopalatine ganglion inducesplasma protein extravasation (PPE) in the rat dura mater, J.Cereb.Blood Flow Metab., 15 (1995)S561.

16. Babbedge, R.C., Bland-Ward, P.A., Hart, S.L. and Moore, P.K., Inhibition of rat cerebellar nitricoxide synthase by 7-nitro indazole and related substituted indazoles, Br.J Pharmacol., 110 (1993)225-228.

17. Bandler, R. and Shipley, M.T., Columnar organization in the midbrain periaqueductal gray:modules for emotional expression?, Trends.Neurosci., 17 (1994) 379-389.

18. Banks, W.A., Ortiz, L., Plotkin, S.R. and Kastin, A.J., Human interleukin (IL) 1 alpha, murine IL-1alpha and murine IL-1 beta are transported from blood to brain in the mouse by a sharedsaturable mechanism., J Pharmacol.Exp.Ther., 259 (1991) 988-996.

19. Barbanti, P., Bronzetti, E., Ricci, A., Cerbo, R., Fabbrini, G., Buzzi, M.G., Amenta, F. and Lenzi,G.L., Increased density of dopamine D-5 receptor in peripheral blood lymphocytes ofmigraineurs: A marker for migraine?, Neurosci.Lett., 207 (1996) 73-76.

20. Bates, D., Ashford, E., Dawson, R. and Ensink, F.B.M., Subcutaneous sumatriptan during themigraine aura, Neurology, 44 (1994) 1587-1587.

21. Battershill, P.E. and Clissold, S.P., Octreotide. A review of its pharmacodynamic andpharmacokinetic properties, and therapeutic potential in conditions associated with excessivepeptide secretion, Drugs, 38 (1989) 658-702.

22. Battistella, P.A., Bordin, A., Cernetti, R., Broetto, S., Corra, S., Piva, E. and Plebani, M., beta-endorphin in plasma and monocytes in juvenile headache, Headache, 36 (1996) 91-94.

References

124

23. Beattie, D.T., Beresford, I.J., Connor, H.E., Marshall, F.H., Hawcock, A.B., Hagan, R.M., Bowers,J., Birch, P.J. and Ward, P., The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist, Br.J.Pharmacol., 116 (1995a) 3149-3157.

24. Beattie, D.T. and Connor, H.E., The pre- and postjunctional activity of CP-122,288, aconformationally restricted analogue of sumatriptan, Eur.J.Pharmacol., 276 (1995b) 271-276.

25. Bedarida, G., Bushell, E., Blaschke, T.F. and Hoffman, B.B., H1- and H2-histamine receptor-mediated vasodilation varies with aging in humans, Clin.Pharmacol.Ther., 58 (1995) 73-80.

26. Bednarczyk, E.M., Remler, B., Weikart, C., Nelson, A.D. and Reed, R.C., Global cerebral bloodflow, blood volume, and oxygen metabolism in patients with migraine headache, Neurology, 50(1998) 1736-1740.

27. Beglinger, C., Born, W., Munch, R., Kurtz, A., Gutzwiller, J.P., Jager, K. and Fischer, J.A., Distincthemodynamic and gastric effects of human CGRP I and II in man, Peptides, 12 (1991) 1347-1351.

28. Behan, W.M., Behan, P.O. and Durward, W.F., Complement studies in migraine, Headache, 21(1981) 55-57.

29. Bentley, D., Katchburian, A. and Brostoff, J., Abdominal migraine and food sensitivity in children,Clin.Allergy, 14 (1984) 499-500.

30. Bereiter, D.A., Morphine and somatostatin analogue reduce c-fos expression in trigeminalsubnucleus caudalis produced by corneal stimulation in the rat, Neuroscience, 77 (1997) 863-874.

31. Berger, S.A., Edberg, S.C. and David, G., Infectious disease in the sella turcica, Rev.Infect.Dis., 8(1986) 747-755.

32. Blau, J.N., Migraine prodromes separated from the aura: complete migraine, Br.Med.J., 281(1980) 658-660.

33. Blau, J.N., Towards a definition of migraine headache, Lancet, 1 (1984) 444-445.34. Blau, J.N. and Thavapalan, M., Preventing migraine: a study of precipitating factors, Headache,

28 (1988) 481-483.35. Bomhof, M.A., Heywood, J., Pradalier, A., Enahoro, H., Winter, P. and Hassani, H., Tolerability

and efficacy of naratriptan tablets with long-term treatment (6 months), Cephalalgia, 18 (1998)33-37.

36. Borges, L.F. and Moskowitz, M.A., Do intracranial and extracranial trigeminal afferents representdivergent axon collaterals?, Neurosci.Lett., 35 (1983) 265-270.

37. Brain, S.D., Tippins, J.R., Morris, H.R., MacIntyre, I. and Williams, T.J., Potent vasodilator activityof calcitonin gene-related peptide in human skin, J.Invest.Dermatol, 87 (1986) 533-536.

38. Brain, S.D. and Williams, T.J., Substance P regulates the vasodilator activity of calcitonin gene-related peptide, Nature, 335 (1988) 73-75.

39. Brain, S.D., Williams, T.J., Tippins, J.R., Morris, H.R. and MacIntyre, I., Calcitonin gene-relatedpeptide is a potent vasodilator, Nature, 313 (1985) 54-56.

40. Brandli, P., Loffler, B.M., Breu, V., Osterwalder, R., Maire, J.P. and Clozel, M., Role of endothelinin mediating neurogenic plasma extravasation in rat dura mater, Pain, 64 (1996) 315-322.

41. Brodin, E., Gazelius, B., Lundberg, J.M. and Olgart, L., Substance P in trigeminal nerve endings:occurrence and release, Acta Physiol.Scand., 111 (1981) 501-503.

42. Bross, J.E. and Gordon, G., Nocardial meningitis: case reports and review, Rev.Infect.Dis., 13(1991) 160-165.

43. Bullitt, E., Expression of c-fos-like protein as a marker for neuronal activity following noxiousstimulation in the rat, J.Comp.Neurol., 296 (1990) 517-530.

44. Burstein, R., Yamamura, H., Malick, A. and Strassman, A.M., Chemical stimulation of theintracranial dura induces enhanced responses to facial stimulation in brain stem trigeminalneurons, J.Neurophysiol., 79 (1998) 964-982.

45. Buzzi, M.G. and Moskowitz, M.A., The antimigraine drug, sumatriptan (GR43175), selectivelyblocks neurogenic plasma extravasation from blood vessels in dura mater, Br.J.Pharmacol., 99(1990) 202-206.

46. Buzzi, M.G. and Moskowitz, M.A., Evidence for 5-HT1B/1D receptors mediating the antimigraineeffect of sumatriptan and dihydroergotamine, Cephalalgia, 11 (1991) 165-168.

References

125

47. Buzzi, M.G. and Moskowitz, M.A., The trigemino-vascular system and migraine,Pathol.Biol.(Paris), 40 (1992) 313-317.

48. Buzzi, M.G., Sakas, D.E. and Moskowitz, M.A., Indomethacin and acetylsalicylic acid blockneurogenic plasma protein extravasation in rat dura mater, Eur.J.Pharmacol., 165 (1989) 251-258.

49. Cadieux, A., Springall, D.R., Mulderry, P.K., Rodrigo, J., Ghatei, M.A., Terenghi, G., Bloom, S.R.and Polak, J.M., Occurrence, distribution and ontogeny of CGRP immunoreactivity in the rat lowerrespiratory tract: effect of capsaicin treatment and surgical denervations, Neuroscience, 19(1986) 605-627.

50. Camazine, B., Shannon, R.P., Guerrero, J.L., Graham, R.M. and Powell, W.J.J., Neurogenichistaminergic vasodilation in canine skeletal muscle: mediation by alpha 2-adrenoceptorstimulation, Circ.Res., 62 (1988) 871-883.

51. Caronti, B., Calderaro, C., Passarelli, F., Palladini, G. and Pontieri, F.E., Dopamine receptormRNAs in the rat lymphocytes, Life Sci., 62 (1998) 1919-1925.

52. Carpenter, S.E. and Lynn, B., Vascular and sensory responses of human skin to mild injury aftertopical treatment with capsaicin, Br.J.Pharmacol., 73 (1981) 755-758.

53. Cechetto, D.F., Standaert, D.G. and Saper, C.B., Spinal and trigeminal dorsal horn projections tothe parabrachial nucleus in the rat, J Comp.Neurol., 240 (1985) 153-160.

54. Cervero, F. and Laird, J.M., Mechanisms of allodynia: interactions between sensitivemechanoreceptors and nociceptors., Neuroreport, 7 (1996) 526-528.

55. Chabriat, H., Danchot, J., Michel, P., Joire, J.E. and Henry, P., Precipitating factors inmigraineurs: a reappraisal in a national control-matched survey, Cephalalgia, 17 (1997) 318-319.

56. Chahl, L.A., The effect of putative peptide neurotransmitters on cutaneous vascular permeabilityin the rat, Naunyn Schmiedebergs Arch.Pharmacol., 309 (1979) 159-163.

57. Chapman, P.B., Lester, T.J., Casper, E.S., Gabrilove, J.L., Wong, G.Y., Kempin, S.J., Gold, P.J.,Welt, S., Warren, R.S., Starnes, H.F. and et, a., Clinical pharmacology of recombinant humantumor necrosis factor in patients with advanced cancer, J Clin.Oncol., 5 (1987) 1942-1951.

58. Chen, F.J., Zhai, Q.H., Bowyer, S., Chopp, M. and Welch, K.M.A., Expression of tumor necrosisfactor alpha, p-selectin and fibrinogen in rat brain after cortical spreading depression,Soc.Neurosci.Abstr., 24 (1998) 1167.

59. Chen, T.C. and Leviton, A., Asthma and eczema in children born to women with migraine,Arch.Neurol., 47 (1990) 1227-1230.

60. Chiba, S. and Tsukada, M., Histamine-induced vasodilations mediated by H1- and H2-receptors inisolated rat common carotid arteries, Heart Vessels, 6 (1991) 185-190.

61. Clayton, J.S., Gaskin, P.J. and Beattie, D.T., Attenuation of Fos-like immunoreactivity in thetrigeminal nucleus caudalis following trigeminovascular activation in the anaesthetised guinea-pig, Brain Res., 775 (1997) 74-80.

62. Clement, C.I., Keay, K.A., Owler, B.K. and Bandler, R., Common patterns of increased anddecreased fos expression in midbrain and pons evoked by noxious deep somatic and noxiousvisceral manipulations in the rat, J Comp.Neurol., 366 (1996) 495-515.

63. Coderre, T.J., Fundytus, M.E., McKenna, J.E., Dalal, S. and Melzack, R., The formalin test: avalidation of the weighted-scores method of behavioural pain rating, Pain, 54 (1993) 43-50.

64. Connor, H.E., Feniuk, W., Beattie, D.T., North, P.C., Oxford, A.W., Saynor, D.A. and Humphrey,P.P., Naratriptan: Biological profile in animal models relevant to migraine, Cephalalgia, 17 (1997)145-152.

65. Contreras, R.J., Beckstead, R.M. and Norgren, R., The central projections of the trigeminal, facial,glossopharyngeal and vagus nerves: an autoradiographic study in the rat, J Auton.Nerv.Syst., 6(1982) 303-322.

66. Covelli, V., Maffione, A.B., Munno, I. and Jirillo, E., Alterations of nonspecific immunity in patientswith common migraine, J.Clin.Lab.Anal., 4 (1990) 9-15.

67. Covelli, V., Massari, F., Conrotto, L., D'Andrea, L., Maffione, A.B., Jirillo, E. and Buscaino, G.A.,Demonstration of an elevated frequency of infectious events in patients with migraine withoutaura: a correlation with their altered immune status, J.Immunol.Immunopharmacol., 13 (1993)173-175.

References

126

68. Covelli, V., Massari, F., Fallacara, C., Munno, I., Pellegrino, N.M., Jirillo, E., Savastano, S., Ghiggi,M.R., Tommaselli, A.P. and Lombardi, G., Increased spontaneous release of tumor necrosisfactor- alpha/cachectin in headache patients. A possible correlation with plasma endotoxin andhypothalamic-pituitary-adrenal axis, Int.J.Neurosci., 61 (1991a) 53-60.

69. Covelli, V., Munno, I., Pellegrino, N.M., Altamura, M., Decandia, P., Marcuccio, C., Di Venere, A.and Jirillo, E., Are TNF-alpha and IL-1 beta relevant in the pathogenesis of migraine withoutaura?, Acta Neurol.(Napoli), 13 (1991b) 205-211.

70. Covelli, V., Munno, I., Pellegrino, N.M., Di, V.A., Jirillo, E. and Buscaino, G.A., Exaggeratedspontaneous release of tumor necrosis factor-alpha-cachectin in patients with migraine withoutaura., Acta Neurol.(Napoli)., 45 (1990) 257-263.

71. Craig, A.D., Spinal and trigeminal lamina I input to the locus coeruleus anterogradely labeled withPhaseolus vulgaris leucoagglutinin (PHA-L) in the cat and the monkey, Brain Res., 584 (1992)325-328.

72. Culp, W.J., Ochoa, J., Cline, M. and Dotson, R., Heat and mechanical hyperalgesia induced bycapsaicin. Cross modality threshold modulation in human C nociceptors., Brain, 112 (1989) 1317-1331.

73. Cumberbatch, M.J., Hill, R.G. and Hargreaves, R.J., Rizatriptan has central antinociceptive effectsagainst durally evoked responses, Eur.J.Pharmacol., 328 (1997) 37-40.

74. Cunha, F.Q., Poole, S., Lorenzetti, B.B. and Ferreira, S.H., The pivotal role of tumour necrosisfactor alpha in the development of inflammatory hyperalgesia, Br.J.Pharmacol., 107 (1992) 660-664.

75. Cutrer, F.M., Limmroth, V., Ayata, G. and Moskowitz, M.A., Attenuation by valproate of c-fosimmunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin,Br.J.Pharmacol., 116 (1995) 3199-3204.

76. Cutrer, F.M., Limmroth, V. and Moskowitz, M.A., Possible mechanisms of valproate in migraineprophylaxis, Cephalalgia, 17 (1997) 93-100.

77. Cutrer, F.M. and Moskowitz, M.A., The actions of valproate and neurosteroids in a model oftrigeminal pain., Headache, 36 (1996) 579-585.

78. Cutrer, F.M., Moussaoui, S., Garret, C. and Moskowitz, M.A., The non-peptide neurokinin-1antagonist, RPR 100893, decreases c- fos expression in trigeminal nucleus caudalis followingnoxious chemical meningeal stimulation, Neuroscience, 64 (1995a) 741-750.

79. Cutrer, F.M., Schoenfeld, D., Limmroth, V., Panahian, N. and Moskowitz, M.A., Suppression bythe sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalisinduced by intracisternal capsaicin, Br.J.Pharmacol., 114 (1995b) 987-987.

80. Czyzyk, K.M., Bayliss, D.A., Seroogy, K.B. and Millhorn, D.E., Gene expression for peptides inneurons of the petrosal and nodose ganglia in rat, Exp.Brain Res., 83 (1991) 411-418.

81. Dalessio, D. J. and Silberstein, S. D. Wolff's headache and other head pain / ed. by Donald J.Dalessio, Stephen D. Silberstein. 6th edition. 1993. New York, Oxford University Press.

82. DelZompo, M., Cherchi, A., Palmas, M.A., Ponti, M., Bocchetta, A., Gessa, G.L. and Piccardi, M.P.,Association between dopamine receptor genes and migraine without aura in a Sardinian sample,Neurology, 51 (1998) 781-786.

83. den Boer, M.O., Villalon, C.M., Heiligers, J.P., Humphrey, P.P. and Saxena, P.R., Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting bysumatriptan, Br.J Pharmacol., 102 (1991) 323-330.

84. Denning, D.W., The neurological features of acute HIV infection, Biomed.Pharmacother., 42(1988) 11-14.

85. Diener, H.C., Substance-P antagonist RPR100893-201 is not effective in human migraineattacks.In: Proceedings of teh VIth Internations Headache Seminar., J. Olesen and P. Tfelt-Hansen (Eds.). New York, Lippincot Raven (1996) pp.

86. Diener, H.C., Peters, C., Rudzio, M., Noe, A., Dichgans, J., Haux, R., Ehrmann, R. and Tfelt-Hansen, P., Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity innormal subjects and migraneurs, J.Neurol., 238 (1991) 245-250.

87. Dimitriadou, V., Buzzi, M.G., Moskowitz, M.A. and Theoharides, T.C., Trigeminal sensory fiberstimulation induces morphological changes reflecting secretion in rat dura mater mast cells,Neuroscience, 44 (1991) 97-112.

References

127

88. Dostrovsky, J.O., Shah, Y. and Gray, B.G., Descending inhibitory influences from periaqueductalgray, nucleus raphe magnus, and adjacent reticular formation. II. Effects on medullary dorsalhorn nociceptive and nonnociceptive neurons, J.Neurophysiol., 49 (1983) 948-960.

89. Dun, N.J., Dun, S.L., Forstermann, U. and Tseng, L.F., Nitric oxide synthase immunoreactivity inrat spinal cord, Neurosci.Lett., 147 (1992) 217-220.

90. Dupouy, V. and Zajac, J.M., Neuropeptide FF receptors control morphine-induced analgesia in theparafascicular nucleus and the dorsal raphe nucleus, Eur.J Pharmacol., 330 (1997) 129-137.

91. Dutschmann, M. and Herbert, H., The medial nucleus of the solitary tract mediates thetrigeminally evoked pressor response, Neuroreport, 9 (1998) 1053-1057.

92. Dzoljic, E., van Leeuwen, R., de Vries, R. and Dzoljic, M.R., Vigilance and EEG power in rats:effects of potent inhibitors of the neuronal nitric oxide synthase, Naunyn Schmiedebergs ArchPharmacol., 356 (1997) 56-61.

93. Dzoljic, M.R., de Vries, R. and van Leeuwen, R., Sleep and nitric oxide: effects of 7-nitro indazole,inhibitor of brain nitric oxide synthase, Brain Res., 718 (1996) 145-150.

94. Edmeads, J., Vascular headaches and the cranial circulation--another look, Headache, 19 (1979)127-132.

95. Edmeads, J., Findlay, H., Tugwell, P., Pryse-Phillips, W., Nelson, R.F. and Murray, T.J., Impact ofmigraine and tension-type headache on life-style, consulting behaviour, and medication use: aCanadian population survey, Can.J.Neurol.Sci., 20 (1993) 131-137.

96. Edvinsson, L., Mulder, H., Goadsby, P.J. and Uddman, R., Calcitonin gene-related peptide andnitric oxide in the trigeminal ganglion: Cerebral vasodilatation from trigeminal nerve stimulationinvolves mainly calcitonin gene-related peptide, J.Auton.Nerv.Syst., 70 (1998) 15-22.

97. Egger, J., Carter, C.M., Wilson, J., Turner, M.W. and Soothill, J.F., Is migraine food allergy? Adouble-blind controlled trial of oligoantigenic diet treatment, Lancet, 2 (1983) 865-869.

98. Ensink, F.B., Subcutaneous sumatriptan in the acute treatment of migraine. SumatriptanInternational Study Group, J.Neurol., 238 Suppl 1 (1991) S66-9.

99. Faggioni, R., Fuller, J., Moser, A., Feingold, K. R., and Grunfeld, C., LPS-induced anorexia inleptin-deficient (ob/ob) and leptin receptor- deficient (db/db) mice, <Journal Name> 42 (1997)R181-R186.

100. Fanciullacci, M., Alessandri, M., Figini, M. and Geppetti, P., Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headacheattack, Pain, VOL 60 (1995) 119-123.

101. Ferguson, A.V. and Lowes, V.L. (Eds), Functional neural connections of the Area Postrema. CRCPress, Boca Raton, 1994.

102. Ferrari, M.D., James, M.H., Bates, D., Pilgrim, A., Ashford, E., Anderson, B.A. and Nappi, G., Oralsumatriptan: effect of a second dose, and incidence and treatment of headache recurrences,Cephalalgia, 14 (1994) 330-338.

103. Ferrari, M.D. and Saxena, P.R., On serotonin and migraine: a clinical and pharmacological review,Cephalalgia, 13 (1993) 151-165.

104. Ferreira, S.H., Lorenzetti, B.B., Bristow, A.F. and Poole, S., Interleukin-1 beta as a potenthyperalgesic agent antagonized by a tripeptide analogue, Nature, 334 (1988) 698-700.

105. Florenzano, F. and De Luca, B., Nociceptive stimulation induces glutamate receptor down-regulation in the trigeminal nucleus, Neuroscience, 90 (1999) 201-207.

106. Friberg, L., Olesen, J., Iversen, H.K. and Sperling, B., Migraine pain associated with middlecerebral artery dilatation: reversal by sumatriptan, Lancet, 338 (1991) 13-17.

107. Frishman, W. and Silverman, R., Clinical pharmacology of the new beta-adrenergic blockingdrugs. Part 3. Comparative clinical experience and new therapeutic applications, Am.Heart J., 98(1979) 119-131.

108. Fritschy, J.M. and Grzanna, R., Demonstration of two separate descending noradrenergicpathways to the rat spinal cord: evidence for an intragriseal trajectory of locus coeruleus axons inthe superficial layers of the dorsal horn, J Comp.Neurol., 291 (1990) 553-582.

109. Fuchs, P.N. and Melzack, R., Restraint reduces formalin-test pain but the effect is not influencedby lesions of the hypothalamic paraventricular nucleus, Exp.Neurol., 139 (1996) 299-305.

110. Fuller, R.W., Conradson, T.B., Dixon, C.M., Crossman, D.C. and Barnes, P.J., Sensoryneuropeptide effects in human skin, Br.J.Pharmacol., 92 (1987) 781-788.

References

128

111. Fulwiler, C.E. and Saper, C.B., Subnuclear organization of the efferent connections of theparabrachial nucleus in the rat, Brain Res., 319 (1984) 229-259.

112. Gallagher, R.M., Acute treatment of migraine with dihydroergotamine nasal spray.Dihydroergotamine Working Group, Arch.Neurol., 53 (1996) 1285-1291.

113. Gallai, V., Sarchielli, P., Floridi, A., Franceschini, Ph.D., Trequattrini, A. and Firenze, C., Monocytefunction in migraine patients with and without aura, Headache Quarterly, 5 (1994) 214-227.

114. Gamse, R., Lembeck, F. and Cuello, A.C., Substance P in the vagus nerve. Immunochemical andimmunohistochemical evidence for axoplasmic transport, Naunyn SchmiedebergsArch.Pharmacol., 306 (1979) 37-44.

115. Gamse, R. and Saria, A., Potentiation of tachykinin-induced plasma protein extravasation bycalcitonin gene-related peptide, Eur.J.Pharmacol., 114 (1985) 61-66.

116. Gasbarrini, A., DeLuca, A., Fiore, G., Gambrielli, M., Franceschi, F., Ojetti, V., Torre, E.S.,Gasbarrini, G., Pola, P. and Giacovazzo, M., Beneficial effects of Helicobacter pylori eradication onmigraine, Hepatogastroenterology., 45 (1998) 765-770.

117. Gaumann, D.M., Grabow, T.S., Yaksh, T.L., Casey, S.J. and Rodriguez, M., Intrathecalsomatostatin, somatostatin analogs, substance P analog and dynorphin A cause comparableneurotoxicity in rats, Neuroscience, 39 (1990) 761-774.

118. Gazelius, B., Brodin, E., Olgart, L. and Panopoulos, P., Evidence that substance P is a mediator ofantidromic vasodilatation using somatostatin as a release inhibitor, Acta Physiol.Scand., 113(1981) 155-159.

119. Geller, E.B. and Wen, P.Y., Migraine with aura as the presentation of leukemia., Headache, 35(1995) 560-562.

120. Gilchrist, H.D., Allard, B.L. and Simone, D.A., Enhanced withdrawal responses to heat andmechanical stimuli following intraplantar injection of capsaicin in rats., Pain, 67 (1996) 179-188.

121. Gilman-Sachs, A., Robbins, L. and Baum, L., Flow cytometric analysis of lymphocyte subsets inperipheral blood of chronic headache patients, Headache, 29 (1989) 290-294.

122. Gloor, P., Migraine and regional cerebral upflow, Trends.Neurosci., 9 (1986) 21.123. Goadsby, P.J., Inhibition of calcitonin gene-related peptide by h-CGRP(8-37) antagonizes the

cerebral dilator response from nasociliary nerve stimulation in the cat, Neurosci.Lett., 151 (1993)13-16.

124. Goadsby, P.J., How do the currently used prophylactic agents work in migraine?, Cephalalgia, 17(1997) 85-92.

125. Goadsby, P.J. and Edvinsson, L., The trigeminovascular system and migraine: studiescharacterizing cerebrovascular and neuropeptide changes seen in humans and cats, Ann.Neurol.,33 (1993) 48-56.

126. Goadsby, P.J. and Edvinsson, L., Joint 1994 Wolff Award Presentation. Peripheral and centraltrigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90,Headache, 34 (1994) 394-399.

127. Goadsby, P.J., Edvinsson, L. and Ekman, R., Release of vasoactive peptides in the extracerebralcirculation of humans and the cat during activation of the trigeminovascular system, Ann.Neurol.,23 (1988) 193-196.

128. Goadsby, P.J., Edvinsson, L. and Ekman, R., Vasoactive peptide release in the extracerebralcirculation of humans during migraine headache, Ann.Neurol., 28 (1990) 183-187.

129. Goadsby, P.J. and Hoskin, K.L., Inhibition of trigeminal neurons by intravenous administration ofthe serotonin (5HT)-1B/D receptor agonist zolmitriptan (311C90): Are brain stem sitestherapeutics target in migraine?, Pain, 67 (1996) 355-359.

130. Goadsby, P.J. and Hoskin, K.L., Serotonin inhibits trigeminal nucleus activity evoked bycraniovascular stimulation through a 5HT(1B/1D) receptor: A central action in migraine?,Ann.Neurol., 43 (1998a) 711-718.

131. Goadsby, P.J., Hoskin, K.L. and Knight, Y.E., Substance P blockade with the potent and centrallyacting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinusstimulation, Neuroscience, 86 (1998b) 337-343.

132. Goadsby, P.J., Knight, Y.E., Hoskin, K.L. and Butler, P., Stimulation of an intracranial trigeminally-innervated structure selectively increases cerebral blood flow, Brain Res, 751 (1997) 247-252.

References

129

133. Goadsby, P.J. and May, A., PET demonstration of hypothalamic activation in cluster headache,Neurology, 52 (1999) 1522.

134. Goadsby, P.J., Zagami, A.S. and Lambert, G.A., Neural processing of craniovascular pain: asynthesis of the central structures involved in migraine, Headache, 31 (1991) 365-371.

135. Gobel, H., Petersen-Braun, M. and Soyka, D., The epidemiology of headache in Germany: anationwide survey of a representative sample on the basis of the headache classification of theInternational Headache Society, Cephalalgia., 14 (1994) 97-106.

136. Goldstein, D.J., Wang, O., Saper, J.R., Stoltz, R., Silberstein, S.D. and Mathew, N.T.,Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study, Cephalalgia., 17(1997) 785-790.

137. Gyr, K.E. and Meier, R., Pharmacodynamic effects of Sandostatin in the gastrointestinal tract,Digestion, 54 Suppl 1:14-9 (1993) 14-19.

138. Haimart, M., Pradalier, A., Launay, J.M., Dreux, C. and Dry, J., Whole blood and plasmahistamine in common migraine, Cephalalgia, 7 (1987) 39-42.

139. Haley, J.E., Dickenson, A.H. and Schachter, M., Electrophysiological evidence for a role of nitricoxide in prolonged chemical nociception in the rat, Neuropharmacology, 31 (1992) 251-258.

140. Hamamura, M., Shibuki, K. and Yagi, K., Noxious inputs to supraoptic neurosecretory cells in therat, Neurosci.Res., 2 (1984) 49-61.

141. Hao, J.X. and Xu, X.J., Treatment of a chronic allodynia-like response in spinally injured rats:effects of systemically administered excitatory amino acid receptor antagonists., Pain, 66 (1996)279-285.

142. Harfstrand, A., Fuxe, K., Kalia, M. and Agnati, L.F., Somatostatin induced apnoea: prevention bycentral and peripheral administration of the opiate receptor blocking agent naloxone, ActaPhysiol.Scand., 125 (1985) 91-95.

143. Harrigan, J.A., Kues, J.R., Ricks, D.F. and Smith, R., Moods that predict coming migraineheadaches, Pain, 20 (1984) 385-396.

144. Harris, J.A., Using c-fos as a neural marker of pain, Brain Res.Bull., 45 (1998) 1-8.145. Headache Classification Committee of the International Headache Society, Classification and

diagnostic criteria for headache disorders, cranial neuralgias and facial pain, Cephalalgia, 8 Suppl7 (1988) 1-96.

146. Heatley, R.V., Denburg, J.A., Bayer, N. and Bienenstock, J., Increased plasma histamine levels inmigraine patients, Clin.Allergy, 12 (1982) 145-149.

147. Hellstrand, K., Hermodsson, S. and Strannegard, O., Evidence for a beta-adrenoceptor-mediatedregulation of human natural killer cells, J Immunol., 134 (1985) 4095-4099.

148. Helmstetter, F.J., Bellgowan, P.S. and Poore, L.H., Microinfusion of mu but not delta or kappaopioid agonists into the basolateral amygdala results in inhibition of the tail flick reflex inpentobarbital-anesthetized rats, J Pharmacol.Exp.Ther., 275 (1995) 381-388.

149. Hemmick, L.M. and Bidlack, J.M., Beta-endorphin stimulates rat T lymphocyte proliferation, JNeuroimmunol., 29 (1990) 239-248.

150. Henry, J.L., Sessle, B.J., Lucier, G.E. and Hu, J.W., Effects of substance P on nociceptive andnon-nociceptive trigeminal brain stem neurons, Pain, 8 (1980) 33-45.

151. Henry, M.A., Johnson, L.R., Nousek Goebl, N. and Westrum, L.E., Light microscopic localization ofcalcitonin gene-related peptide in the normal feline trigeminal system and followingretrogasserian rhizotomy, J.Comp.Neurol., 365 (1996) 526-540.

152. Herbert, H., Moga, M.M. and Saper, C.B., Connections of the parabrachial nucleus with thenucleus of the solitary tract and the medullary reticular formation in the rat, J.Comp.Neurol., 293(1990) 540-580.

153. Herbert, M.K. and Holzer, P., Interleukin-1 beta enhances capsaicin-induced neurogenicvasodilatation in the rat skin, Br.J.Pharmacol., 111 (1994) 681-686.

154. Hermanson, O. and Blomqvist, A., Preproenkephalin messenger RNA-expressing neurons in therat parabrachial nucleus: subnuclear organization and projections to the intralaminar thalamus,Neuroscience, 81 (1997) 803-812.

155. Holzer, H.H., Turkelson, C.M., Solomon, T.E. and Raybould, H.E., Intestinal lipid inhibits gastricemptying via CCK and a vagal capsaicin-sensitive afferent pathway in rats, Am.J.Physiol., 267(1994) G625-9.

References

130

156. Holzer, P., Local effector functions of capsaicin-sensitive sensory nerve endings: involvement oftachykinins, calcitonin gene-related peptide and other neuropeptides, Neuroscience, 24 (1988)739-768.

157. Hoskin, K.L. and Goadsby, P.J., Comparison of more and less lipophilic serotonin (5HT(1B/1D))agonists in a model of trigeminovascular nociception in cat, Exp.Neurol., 150 (1998) 45-51.

158. Hoskin, K.L., Kaube, H. and Goadsby, P.J., Central activation of the trigeminovascular pathway inthe cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study, Brain, 119(1996a) 249-256.

159. Hoskin, K.L., Kaube, H. and Goadsby, P.J., Sumatriptan can inhibit trigeminal afferents by anexclusively neural mechanism., Brain, 119 (1996b) 1419-1428.

160. Hoyer, D., Bell, G.I., Berelowitz, M., Epelbaum, J., Feniuk, W., Humphrey, P.P., O'Carroll, A.M.,Patel, Y.C., Schonbrunn, A. and Taylor, J.E., Classification and nomenclature of somatostatinreceptors, Trends.Pharmacol.Sci., 16 (1995) 86-88.

161. Hua, X.Y., Chen, P., Fox, A. and Myers, R.R., Involvement of cytokines in lipopolysaccharide-induced facilitation of CGRP release from capsaicin-sensitive nerves in the trachea: studies withinterleukin-1beta and tumor necrosis factor-alpha, J.Neurosci., 16 (1996) 4742-4748.

162. Hunt, S.P., Pini, A. and Evan, G., Induction of c-fos-like protein in spinal cord neurons followingsensory stimulation, Nature, 328 (1987) 632-634.

163. Idris, A.S., Isbak, S. and Hassan, K., Platelet function and allergic tendency in migraine patientsbefore treatment: a preliminary study, Cephalalgia, 9 (1989) 95.

164. Ingvardsen, B.K., Laursen, H., Olsen, U.B. and Hansen, A.J., Possible mechanism of c-fosexpression in trigeminal nucleus caudalis following cortical spreading depression, Pain, 72 (1997)407-415.

165. Isler, H., Headache classification prior to the Ad Hoc criteria, Cephalalgia, 13 Suppl 12:9-10(1993) 9-10.

166. Iversen, H.K., Nielsen, T.H., Olesen, J. and Tfelt, H.P., Arterial responses during migraineheadache, Lancet, 336 (1990) 837-839.

167. Iversen, H.K. and Olesen, J., Nitroglycerin-induced headache is not dependent on histaminerelease: support for a direct nociceptive action of nitric oxide, Cephalalgia, 14 (1994) 437-442.

168. Iversen, H.K. and Olesen, J., Headache induced by a nitric oxide donor (nitroglycerin) respondsto sumatriptan. A human model for development of migraine drugs., Cephalalgia, 16 (1996) 412-418.

169. Iversen, H.K., Olesen, J. and Tfelt-Hansen, P., Intravenous nitroglycerin as an experimentalmodel of vascular headache. Basic characteristics, Pain, 38 (1989) 17-24.

170. Iwamoto, I. and Nadel, J.A., Tachykinin receptor subtype that mediates the increase in vascularpermeability in guinea pig skin, Life Sci., 44 (1989) 1089-1095.

171. Jacquin, M.F., Semba, K., Rhoades, R.W. and Egger, M.D., Trigeminal primary afferents projectbilaterally to dorsal horn and ipsilaterally to cerebellum, reticular formation, and cuneate, solitary,supratrigeminal and vagal nuclei, Brain Res., 246 (1982) 285-291.

172. Jancso, G., Intracisternal capsaicin: selective degeneration of chemosensitive primary sensoryafferents in the adult rat, Neurosci.Lett., 27 (1981) 41-45.

173. Jancso, N., Jancso-Gabor, A. and Szolcsanyi, J., Direct evidence for neurogenic inflammation andits prevention by denervation and by pretreatment with capsaicin, Br.J.Pharmacol., 31 (1967)138-151.

174. Jansen, I., Alafaci, C., Uddman, R. and Edvinsson, L., Evidence that calcitonin gene-relatedpeptide contributes to the capsaicin-induced relaxation of guinea pig cerebral arteries,Regul.Pept., 31 (1990) 167-178.

175. Janss, A.J., Jones, S.L. and Gebhart, G.F., Effect of spinal norepinephrine depletion ondescending inhibition of the tail flick reflex from the locus coeruleus and lateral reticular nucleusin the rat, Brain Res., 400 (1987) 40-52.

176. Jasmin, L., Burkey, A.R., Card, J.P. and Basbaum, A.I., Transneuronal labeling of a nociceptivepathway, the spino(trigemino- )parabrachio-amygdaloid, in the rat, J Neurosci, 17 (1997) 3751-3765.

177. Jerzmanowski, A. and Klimek, A., Immunoglobulins and complement in migraine, Cephalalgia, 3(1983) 119-123.

References

131

178. Johnson, K.W. and Phebus, L.A., A fluorescence-based method for assessing dural proteinextravasation induced by trigeminal ganglion stimulation, J.Neurosci.Methods, 81 (1998) 19-24.

179. Jones, S.L. and Gebhart, G.F., Quantitative characterization of ceruleospinal inhibition ofnociceptive transmission in the rat, J Neurophysiol., 56 (1986) 1397-1410.

180. Juranek, I. and Lembeck, F., Evidence for the participation of glutamate in reflexes involvingafferent, substance P-containing nerve fibres in the rat, Br.J Pharmacol., 117 (1996) 71-78.

181. Kalisch, B.E., Connop, B.P., Jhamandas, K., Beninger, R.J. and Boegman, R.J., Differential actionof 7-nitro indazole on rat brain nitric oxide synthase, Neurosci.Lett., 219 (1996) 75-78.

182. Kapicioglu, S., Gokce, E., Kapicioglu, Z. and Ovali, E., Treatment of migraine attacks with a long-acting somatostatin analogue (Octreotide, SMS 201-995), Cephalalgia, 17 (1997) 27-30.

183. Kataeva, G., Agro, A. and Stanisz, A.M., Substance-P-mediated intestinal inflammation: inhibitoryeffects of CP 96,345 and SMS 201-995, Neuroimmunomodulation., 1 (1994) 350-356.

184. Kaube, H., Hoskin, K.L. and Goadsby, P.J., Activation of the trigeminovascular system bymechanical distension of the superior sagittal sinus in the cat, Cephalalgia., 12 (1992) 133-136.

185. Kaube, H., Hoskin, K.L. and Goadsby, P.J., Inhibition by sumatriptan of central trigeminalneurones only after blood-brain barrier disruption, Br.J.Pharmacol., 109 (1993a) 788-792.

186. Kaube, H., Hoskin, K.L. and Goadsby, P.J., Intravenous acetylsalicylic acid inhibits centraltrigeminal neurons in the dorsal horn of the upper cervical spinal cord in the cat, Headache., 33(1993b) 541-544.

187. Kaube, H., Keay, K.A., Hoskin, K.L., Bandler, R. and Goadsby, P.J., Expression of c-Fos-likeimmunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of thesuperior sagittal sinus in the cat, Brain Res., 629 (1993c) 95-102.

188. Keay, K.A. and Bandler, R., Deep and superficial noxious stimulation increases Fos-likeimmunoreactivity in different regions of the midbrain periaqueductal gray of the rat,Neurosci.Lett., 154 (1993) 23-26.

189. Keay, K.A. and Bandler, R., Vascular head pain selectively activates ventrolateral periaqueductalgray in the cat, Neurosci.Lett., 245 (1998) 58-60.

190. Keller, J.T., Beduk, A. and Saunders, M.C., Origin of fibers innervating the basilar artery of thecat, Neurosci.Lett., 58 (1985a) 263-268.

191. Keller, J.T., Saunders, M.C., Beduk, A. and Jollis, J.G., Innervation of the posterior fossa dura ofthe cat, Brain Res.Bull., 14 (1985b) 97-102.

192. Kemper, R.H.A., Meijler, W.J. and TerHorst, G.J., Trigeminovascular stimulation in conscious rats,Neuroreport, 8 (1997) 1123-1126.

193. Kemper, R.H.A., Spoelstra, M.B., Meijler, W.J. and Ter Horst, G.J., LPS induced hyperalgesia ofintracranial capsaicin sensitive afferents in the conscious rat, Pain, 78 (1998) 181-190.

194. Khalil, Z., Andrews, P.V. and Helme, R.D., VIP modulates substance P-induced plasmaextravasation in vivo, Eur.J.Pharmacol., 151 (1988) 281-287.

195. Kidd, M., Miu, K., Tang, L.H., Perez, P.G., Blaser, M.J., Sandor, A. and Modlin, I.M., Helicobacterpylori lipopolysaccharide stimulates histamine release and DNA synthesis in rat enterochromaffin-like cells, Gastroenterology, 113 (1997) 1110-1117.

196. Kimmel, D.W., The nerves of the cranial dura mater and their significance in dural headache andreferred pain, The Quarterly, 22 (1961) 12-26.

197. Kitazawa, T., Terasaki, T., Suzuki, H., Kakee, A. and Sugiyama, Y., Efflux of taurocholic acidacross the blood-brain barrier: interaction with cyclic peptides, J Pharmacol.Exp.Ther., 286(1998) 890-895.

198. Klamt, J.G. and Prado, W.A., Antinociception and behavioral changes induced by carbacholmicroinjected into identified sites of the rat brain, Brain Res., 549 (1991) 9-18.

199. Klatt, D.S., Guinan, M.J., Culhane, E.S., Carstens, E. and Watkins, L.R., The dorsal raphe nucleus:a re-evaluation of its proposed role in opiate analgesia systems, Brain Res., 447 (1988) 246-252.

200. Knowles, R.G. and Moncada, S., Nitric oxide synthases in mammals, Biochem.J, 298 (1994) 249-258.

201. Knyiharcsillik, E., Tajti, J., Samsam, M., Sary, G., Slezak, S. and Vecsei, L., Effect of a serotoninagonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on theexpression of c- fos in the caudal trigeminal nucleus in an experimental migraine model,J.Neurosci.Res, 48 (1997) 449-464.

References

132

202. Kowacs, P.A. and Werneck, L.C., Atenolol prophylaxis in migraine secondary to an arteriovenousmalformation., Headache, 36 (1996) 625-627.

203. Kowalski, M.L., Sliwinska-Kowalska, M. and Kaliner, M.A., Neurogenic inflammation, vascularpermeability, and mast cells. II. Additional evidence indicating that mast cells are not involved inneurogenic inflammation, J.Immunol., 145 (1990) 1214-1221.

204. Kuritzky, A., Bennet, E., Hering, R. and Ebstein, R., Reduced sensitivity of lymphocyte beta-adrenergic receptors in migraine, Headache, 33 (1993) 198-200.

205. Kurzrock, R., Feinberg, B., Talpaz, M., Saks, S. and Gutterman, J.U., Phase I study of acombination of recombinant tumor necrosis factor-alpha and recombinant interferon-gamma incancer patients, J Interferon.Res., 9 (1989) 435-444.

206. Kusnecov, A.W., Husband, A.J., King, M.G., Pang, G. and Smith, R., In vivo effects of beta-endorphin on lymphocyte proliferation and interleukin 2 production, Brain Behav.Immun., 1(1987) 88-97.

207. Lacombe, P., Sercombe, R., Correze, J.L., Springhetti, V. and Seylaz, J., Spreading depressioninduces prolonged reduction of cortical blood flow reactivity in the rat, Exp.Neurol., 117 (1992)278-286.

208. Laight, D.W., Woodward, B. and Waterfall, J.F., Renal vasodilation to histamine in vitro: roles ofnitric oxide, cyclo-oxygenase products and H2 receptors, Inflamm.Res., 44 (1995) 116-120.

209. Lambert, G.A., Bogduk, N., Goadsby, P.J., Duckworth, J.W. and Lance, J.W., Decreased carotidarterial resistance in cats in response to trigeminal stimulation, J.Neurosurg., 61 (1984a) 307-315.

210. Lambert, G.A., Duckworth, J.W., Bogduk, N. and Lance, J.W., Low pharmacologicalresponsiveness of the vertebro-basilar circulation in Macaca nemestrina monkeys,Eur.J.Pharmacol., 102 (1984b) 451-458.

211. Lambert, G.A., Goadsby, P.J., Zagami, A.S. and Duckworth, J.W., Comparative effects ofstimulation of the trigeminal ganglion and the superior sagittal sinus on cerebral blood flow andevoked potentials in the cat, Brain Res., 453 (1988) 143-149.

212. Lambert, G.A., Lowy, A.J., Boers, P.M., Angus Leppan, H. and Zagami, A.S., The spinal cordprocessing of input from the superior sagittal sinus: pathway and modulation by ergot alkaloids,Brain Res., 597 (1992) 321-330.

213. Lamour, Y., Guilbaud, G. and Willer, J.C., Rat somatosensory (SmI) cortex: II. Laminar andcolumnar organization of noxious and non-noxious inputs, Exp.Brain Res., 49 (1983a) 46-54.

214. Lamour, Y., Willer, J.C. and Guilbaud, G., Rat somatosensory (SmI) cortex: I. Characteristics ofneuronal responses to noxious stimulation and comparison with responses to non- noxiousstimulation, Exp.Brain Res., 49 (1983b) 35-45.

215. Lance, J.W., Lambert, G.A., Goadsby, P.J. and Duckworth, J.W., Brainstem influences on thecephalic circulation: experimental data from cat and monkey of relevance to the mechanism ofmigraine, Headache, 23 (1983) 258-265.

216. Lane, H.C., Davey-RT, J., Sherwin, S.A., Masur, H., Rook, A.H., Manischewitz, J.F., Quinnan,G.V., Smith, P.D., Easter, M.E. and Fauci, A.S., A phase I trial of recombinant human interferon-gamma in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS), JClin.Immunol., 9 (1989) 351-361.

217. Lassen, L.H., Ashina, M., Christiansen, I., Ulrich, V., Grover, R., Donaldson, J. and Olesen, J.,Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks,Cephalalgia., 18 (1998) 27-32.

218. Lassen, L.H., Ashina, M., Christiansen, I., Ulrich, V. and Olesen, J., Nitric oxide synthase inhibitionin migraine, Lancet, 349 (1997) 401-402.

219. Lassen, L.H., Heinig, J.H., Oestergaard, S. and Olesen, J., Histamine inhalation is a specific butinsensitive laboratory test for migraine., Cephalalgia, 16 (1996a) 550-553.

220. Lassen, L.H., Thomsen, L.L., Kruuse, C., Iversen, H.K. and Olesen, J., Histamine-1 receptorblockade does not prevent nitroglycerin induced migraine: Support for the NO-hypothesis ofmigraine., European Journal of Clinical Pharmacology, 49 (1996b) 335-339.

221. Lassen, L.H., Thomsen, L.L. and Olesen, J., Histamine induces migraine via the H1-receptor.Support for the NO hypothesis of migraine, Neuroreport, 6 (1995a) 1475-1479.

References

133

222. Lassen, L.H., Thomson, L.L. and Olesen, J., Histamine induces both immediate and delayedheadache in migraineurs due to H1-receptor activation. Support for the No- hypothesis ofmigraine, J.Cereb.Blood Flow Metab., 15 (1995b) S168.

223. Lauritzen, M., Pathophysiology of the migraine aura. The spreading depression theory, Brain, 117(1994) 199-210.

224. Lauritzen, M., Jorgensen, M.B., Diemer, N.H., Gjedde, A. and Hansen, A.J., Persistent oligemia ofrat cerebral cortex in the wake of spreading depression, Ann.Neurol., 12 (1982) 469-474.

225. Laviano, A., Renvyle, T., Meguid, M.M., Yang, Z.J., Cangiano, C. and Rossi, F.F., Relationshipbetween interleukin-1 and cancer anorexia, Nutrition., 11 (1995) 680-683.

226. Lee, J.H., Wilcox, G.L. and Beitz, A.J., Nitric oxide mediates Fos expression in the spinal cordinduced by mechanical noxious stimulation, Neuroreport, 3 (1992) 841-844.

227. Lee, W.S., Limmroth, V., Ayata, C. and Cutrer, F.M., Peripheral GABA~A receptor-mediatedeffects of sodium valproate on dural plasma protein extravasation to substance P and trigeminalstimulation, Br.J.Pharmacol., 116 (1995) 1661-1661.

228. Leonardi, M., Musicco, M. and Nappi, G., Headache as a major public health problem: currentstatus, Cephalalgia., 18 (1998) 66-69.

229. Leone, M., Biffi, M., Leoni, F. and Bussone, G., Leukocyte subsets and cortisol serum levels inpatients with migraine without aura and chronic tension-type headache, Cephalalgia., 14 (1994)139-142.

230. Leone, M., Sacerdote, P., D'Amico, D., Panerai, A.E. and Bussone, G., Beta-endorphinconcentrations in the peripheral blood mononuclear cells of migraine and tension-type headachepatients, Cephalalgia., 12 (1992) 154-157.

231. Lesne, E. and Richet, C., Anaphylaxic alimentaire aux ceufs, Arch.Mal.Enfants, 16 (1913) 81.232. Levine, R., Morgan, M.M., Cannon, J.T. and Liebeskind, J.C., Stimulation of the periaqueductal

gray matter of the rat produces a preferential ipsilateral antinociception, Brain Res., 567 (1991)140-144.

233. Li, J.L., Kaneko, T., Nomura, S., Li, Y.Q. and Mizuno, N., Association of serotonin-likeimmunoreactive axons with nociceptive projection neurons in the caudal spinal trigeminal nucleusof the rat, J.Comp.Neurol., 384 (1997) 127-141.

234. Li, Y.Q., Takada, M., Matsuzaki, S., Shinonaga, Y. and Mizuno, N., Identification of periaqueductalgray and dorsal raphe nucleus neurons projecting to both the trigeminal sensory complex andforebrain structures: a fluorescent retrograde double-labeling study in the rat., Brain Res, 623(1993) 267-277.

235. Li, Y.Q., Takada, M., Ohishi, H., Shinonaga, Y. and Mizuno, N., Trigeminal ganglion neuronswhich project by way of axon collaterals to both the caudal spinal trigeminal and the principalsensory trigeminal nuclei, Brain Res., 594 (1992) 155-159.

236. Lichtman, A.H., Cook, S.A. and Martin, B.R., Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement, JPharmacol.Exp.Ther., 276 (1996) 585-593.

237. Limmroth, V., May, A. and Diener, H., Lysine-acetylsalicylic acid in acute migraine attacks,Eur.Neurol., 41 (1999) 88-93.

238. Liu Chen, L.Y., Mayberg, M.R. and Moskowitz, M.A., Immunohistochemical evidence for asubstance P-containing trigeminovascular pathway to pial arteries in cats, Brain Res., 268 (1983)162-166.

239. Liveing, E. On Megrim, Sick-Headache, and Some Allied Disorders. Congress Edition (1997).1873. Nijmegen, the Netherlands, Arts & Boeve.

240. Loisy, C., Arnaud, J.L. and Amelot, A., Contribution to the study of histamine metabolism inmigrainous subjects, Res.Clin.Stud.Headache., 3 (1970) 252-259.

241. Long, N.C., Otterness, I., Kunkel, S.L., Vander, A.J. and Kluger, M.J., Roles of interleukin 1 betaand tumor necrosis factor in lipopolysaccharide fever in rats, Am.J.Physiol., 259 (1990) R724-8.

242. Lord, G.D. and Duckworth, J.W., Immunoglobulin and complement studies in migraine,Headache, 17 (1977a) 163-168.

243. Lord, G.D., Duckworth, J.W. and Charlesworth, J.A., Complement activation in migraine, Lancet,1 (1977b) 781-782.

References

134

244. Lovick, T.A., The periaqueductal gray-rostral medulla connection in the defence reaction: efferentpathways and descending control mechanisms, Behav.Brain Res., 58 (1993) 19-25.

245. Lovick, T.A. and Robinson, J.P., Bulbar raphe neurones with projections to the trigeminal nucleuscaudalis and the lumbar cord in the rat: a fluorescence double- labelling study, Exp.Brain Res., 50(1983) 299-308.

246. Lovick, T.A. and Wolstencroft, J.H., Inhibitory effects of nucleus raphe magnus on neuronalresponses in the spinal trigeminal nucleus to nociceptive compared with non-nociceptive inputs,Pain, 7 (1979) 135-145.

247. Lundberg, J.M. and Saria, A., Capsaicin-sensitive vagal neurons involved in control of vascularpermeability in rat trachea, Acta Physiol.Scand., 115 (1982) 521-523.

248. MacKenzie, G.M., Rose, S., Bland-Ward, P.A., Moore, P.K., Jenner, P. and Marsden, C.D., Timecourse of inhibition of brain nitric oxide synthase by 7- nitro indazole, Neuroreport., 5 (1994)1993-1996.

249. Maggi, C.A., The pharmacological modulation of neurotransmitter release.In: Capsaicin in thestudy of pain., J. Wood (Ed.). San Diego, Academic Press Limited (1993) pp. 161-189.

250. Maggi, C.A. and Meli, A., The sensory-efferent function of capsaicin-sensitive sensory neurons,Gen.Pharmacol., 19 (1988) 1-43.

251. Maggi, C.A., Patacchini, R., Santicioli, P. and Giuliani, S., Tachykinin antagonists and capsaicin-induced contraction of the rat isolated urinary bladder: evidence for tachykinin-mediatedcotransmission, Br.J.Pharmacol., 103 (1991) 1535-1541.

252. Mahara, F., Japanese spotted fever: report of 31 cases and review of the literature,Emerg.Infect.Dis., 3 (1997) 105-111.

253. Malick, A. and Burstein, R., Cells of origin of the trigeminohypothalamic tract in the rat, JComp.Neurol., 400 (1998) 125-144.

254. Manning, B.H. and Mayer, D.J., The central nucleus of the amygdala contributes to theproduction of morphine antinociception in the formalin test, Pain, 63 (1995a) 141-152.

255. Manning, B.H. and Mayer, D.J., The central nucleus of the amygdala contributes to theproduction of morphine antinociception in the rat tail-flick test, J Neurosci., 15 (1995b) 8199-8213.

256. Mansfield, L.E., The role of antihistamine therapy in vascular headaches, J.Allergy Clin.Immunol.,86 (1990) 673-676.

257. Mansfield, L.E., Vaughan, T.R., Waller, S.F., Haverly, R.W. and Ting, S., Food allergy and adultmigraine: double-blind and mediator confirmation of an allergic etiology, Ann.Allergy, 55 (1985)126-129.

258. Marcussen, R.M. and Wolff, H.G., Studies on headache: 1. effects of carbon dioxide-oxygenmixture given during the pre-headache phase of the migraine attack; 2. further analysis of painmechanisms in headache, Arch.Neurol.Psychiat., 63 (1950) 42-51.

259. Margalit, D. and Segal, M., A pharmacologic study of analgesia produced by stimulation of thenucleus locus coeruleus, Psychopharmacology (Berl.), 62 (1979) 169-173.

260. Markowitz, S., Saito, K., Buzzi, M.G. and Moskowitz, M.A., The development of neurogenicplasma extravasation in the rat dura mater does not depend upon the degranulation of mastcells, Brain Res., 477 (1989) 157-165.

261. Markowitz, S., Saito, K. and Moskowitz, M.A., Neurogenically mediated leakage of plasma proteinoccurs from blood vessels in dura mater but not brain, J.Neurosci., 7 (1987) 4129-4136.

262. Markowitz, S., Saito, K. and Moskowitz, M.A., Neurogenically mediated plasma extravasation indura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache,Cephalalgia, 8 (1988) 83-91.

263. Martelletti, P., Stirparo, G., Morrone, S., Rinaldi, C. and Giacovazzo, M., Inhibition of intercellularadhesion molecule-1 (ICAM-1), soluble ICAM-1 and interleukin-4 by nitric oxide expression inmigraine patients, J.Molecular Med., 75 (1997) 448-453.

264. Martelletti, P., Stirparo, G., Rinaldi, C., Frati, L. and Giacovazzo, M., Disruption of theimmunopeptidergic network in dietary migraine, Headache, 33 (1993) 524-527.

265. Martelletti, P., Sutherland, J., Anastasi, E., Di Mario, U. and Giacovazzo, M., Evidence for animmune-mediated mechanism in food-induced migraine from a study on activated T-cells, IgG4subclass, anti- IgG antibodies and circulating immune complexes, Headache., 29 (1989) 664-670.

References

135

266. Martin, G.R., Robertson, A.D., MacLennan, S.J., Prentice, D.J., Barrett, V.J., Buckingham, J.,Honey, A.C., Giles, H. and Moncada, S., Receptor specificity and trigemino-vascular inhibitoryactions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (Zolmitriptan), Br J Pharmacol,121 (1997) 157-164.

267. Martin, W.J., Patrick, S.L., Coffin, P.O., Tsou, K. and Walker, J.M., An examination of the centralsites of action of cannabinoid-induced antinociception in the rat, Life Sci., 56 (1995) 2103-2109.

268. Martinez, S. and Belmonte, C., C-Fos expression in trigeminal nucleus neurons after chemicalirritation of the cornea: reduction by selective blockade of nociceptor chemosensitivity, Exp.BrainRes., 109 (1996) 56-62.

269. Masini, E., Bechi, P., Dei, R., Di, B.M. and Sacchi, T.B., Helicobacter pylori potentiates histaminerelease from rat serosal mast cells induced by bile acids, Dig.Dis.Sci., 39 (1994) 1493-1500.

270. Massari, F., D'Andrea, L., Cervo, M.A., Serra, F.P., Covelli, V. and Buscaino, G.A., Quantitativeand qualitative modifications of lymphocyte subsets after sublingual administration of isosorbidedinitrate in migraineurs. Preliminary report, Acta Neurol.(Napoli), 16 (1994) 11-18.

271. Massari, V.J., Tizabi, Y., Park, C.H., Moody, T.W., Helke, C.J. and O'Donohue, T.L., Distributionand origin of bombesin, substance P and somatostatin in cat spinal cord, Peptides, 4 (1983) 673-681.

272. Mathew, N.T., Asgharnejad, M., Peykamian, M. and Laurenza, A., Naratriptan is effective and welltolerated in the acute treatment of migraine - Results of a double-blind, placebo-controlled,crossover study, Neurology, 49 (1997) 1485-1490.

273. Mathew, N.T., Dexter, J., Couch, J., Flamenbaum, W., Goldstein, J., Rapoport, A., Sheftell, F.,Saper, J., Silberstein, S., Solomon, S. and et al, Dose ranging efficacy and safety of subcutaneoussumatriptan in the acute treatment of migraine. US Sumatriptan Research Group, Arch.Neurol.,49 (1992) 1271-1276.

274. Matsubara, T., Moskowitz, M.A. and Byun, B., CP-93,129, a potent and selective 5-HT1B receptoragonist blocks neurogenic plasma extravasation within rat but not guinea-pig dura mater,Br.J.Pharmacol., 104 (1991) 3-4.

275. Matsubara, T., Moskowitz, M.A. and Huang, Z., UK-14,304, R(-)-alpha-methyl-histamine and SMS201-995 block plasma protein leakage within dura mater by prejunctional mechanisms,Eur.J.Pharmacol., 224 (1992) 145-150.

276. Mavromichalis, I., Zaramboukas, T. and Giala, M.M., Migraine of gastrointestinal origin, Eur.JPediatr., 154 (1995) 406-410.

277. May, A., Gijsman, H.J., Wallnofer, A., Jones, R., Diener, H.C. and Ferrari, M.D., Endothelinantagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraineattacks., Pain, 67 (1996) 375-378.

278. May, A. and Goadsby, P.J., The trigeminovascular system in humans: pathophysiologicimplications for primary headache syndromes of the neural influences on the cerebral circulation,J Cereb.Blood Flow Metab., 19 (1999) 115-127.

279. May, A., Kaube, H., Buchel, C., Eichten, C., Rijntjes, M., Juptner, M., Weiller, C. and Diener, H.C.,Experimental cranial pain elicited by capsaicin: a PET study, Pain, 74 (1998) 61-66.

280. Mayberg, M., Langer, R.S., Zervas, N.T. and Moskowitz, M.A., Perivascular meningeal projectionsfrom cat trigeminal ganglia: possible pathway for vascular headaches in man, Science, 213(1981) 228-230.

281. Mayberg, M.R., Zervas, N.T. and Moskowitz, M.A., Trigeminal projections to supratentorial pialand dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry,J.Comp.Neurol., 223 (1984) 46-56.

282. McHugh, K.J., Collins, S.M. and Weingarten, H.P., Central interleukin-1 receptors contribute tosuppression of feeding after acute colitis in the rat, Am.J Physiol., 266 (1994) R1659-R1663.

283. McLeod, R.L., Aslanian, R., Del Prado, M., Duffy, R., Egan, R.W., Kreutner, W., McQuade, R. andHey, J.A., Sch 50971, an orally active histamine H3 receptor agonist, inhibits central neurogenicvascular inflammation and produces sedation in the guinea pig, J Pharmacol.Exp.Ther., 287(1998) 43-50.

284. Medina, J.L. and Diamond, S., Migraine and atopy, Headache, 16 (1976) 271-274.285. Meller, S.T. and Gebhart, G.F., Nitric oxide (NO) and nociceptive processing in the spinal cord,

Pain, 52 (1993) 127-136.

References

136

286. Menetrey, D. and Basbaum, A.I., Spinal and trigeminal projections to the nucleus of the solitarytract: a possible substrate for somatovisceral and viscerovisceral reflex activation,J.Comp.Neurol., 255 (1987) 439-450.

287. Menetrey, D., Gannon, A., Levine, J.D. and Basbaum, A.I., Expression of c-fos protein ininterneurons and projection neurons of the rat spinal cord in response to noxious somatic,articular, and visceral stimulation, J.Comp.Neurol., 285 (1989) 177-195.

288. Meng, I.D., Hu, J.W., Benetti, A.P. and Bereiter, D.A., Encoding of corneal input in two distinctregions of the spinal trigeminal nucleus in the rat: Cutaneous receptive field properties,responses to thermal and chemical stimulation, modulation by diffuse noxious inhibitory controls,and projections to the parabrachial area, J Neurophysiol., 77 (1997) 43-56.

289. Merighi, A., Polak, J.M. and Theodosis, D.T., Ultrastructural visualization of glutamate andaspartate immunoreactivities in the rat dorsal horn, with special reference to the co-localizationof glutamate, substance P and calcitonin-gene related peptide, Neuroscience, 40 (1991) 67-80.

290. Merrett, J., Peatfield, R.C., Rose, F.C. and Merrett, T.G., Food related antibodies in headachepatients, J.Neurol.Neurosurg.Psychiatry, 46 (1983) 738-742.

291. Messlinger, K., Hanesch, U., Kurosawa, M., Pawlak, M. and Schmidt, R.F., Calcitonin gene relatedpeptide released from dural nerve fibers mediates increase of meningeal blood flow in the rat,Can.J.Physiol.Pharmacol., 73 (1995) 1020-1024.

292. Michaud, J.C., Alonso, R., Gueudet, C., Fournier, M., Calassi, R., Breliere, J.C., LeFur, G. andSoubrie, P., Effects of SR140333, a selective non-peptide NK1 receptor antagonist, on trigemino-thalamic nociceptive pathways in the rat, Fundam.Clin.Pharmacol., 12 (1998) 88-94.

293. Miczek, K.A., Nikulina, E., Kream, R.M., Carter, G. and Espejo, E.F., Behavioral sensitization tococaine after a brief social defeat stress: c-fos expression in the PAG, Psychopharmacology(Berl.), 141 (1999) 225-234.

294. Mier, J.W., Aronson, F.R., Numerof, R.P., Vachino, G. and Atkins, M.B., Toxicity ofimmunotherapy with interleukin-2 and lymphokine-activated killer cells,Pathol.Immunopathol.Res., 7 (1988) 459-476.

295. Mirro, R., Busija, D.W., Armstead, W.M. and Leffler, C.W., Histamine dilates pial arterioles ofnewborn pigs through prostanoid production, Am.J.Physiol., 254 (1988) H1023-H1026.

296. Mitsikostas, D.D., delRio, M.S., Waeber, C., Moskowitz, M.A. and Cutrer, F.M., The NMDAreceptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminalnucleus caudalis, Pain, 76 (1998) 239-248.

297. Mitsikostas, D.D., Sanchez, d.R., Moskowitz, M.A. and Waeber, C., Both 5-HT1B and 5-HT1Freceptors modulate c-fos expression within rat trigeminal nucleus caudalis, Eur.J Pharmacol., 369(1999) 271-277.

298. Mogil, J.S., Wilson, S.G., Bon, K., Lee, S.E., Chung, K., Raber, P., Pieper, J.O., Hain, H.S.,Belknap, J.K., Hubert, L., Elmer, G.I., Chung, J.M. and Devor, M., Heritability of nociception I:responses of 11 inbred mouse strains on 12 measures of nociception, Pain, 80 (1999) 67-82.

299. Monro, J., Brostoff, J., Carini, C. and Zilkha, K., Food allergy in migraine. Study of dietaryexclusion and RAST, Lancet, 2 (1980) 1-4.

300. Monroe, P.J., Hawranko, A.A., Smith, D.L. and Smith, D.J., Biochemical and pharmacologicalcharacterization of multiple beta- endorphinergic antinociceptive systems in the ratperiaqueductal gray, J Pharmacol.Exp.Ther., 276 (1996) 65-73.

301. Moore, P.K., Babbedge, R.C., Wallace, P., Gaffen, Z.A. and Hart, S.L., 7-Nitro indazole, aninhibitor of nitric oxide synthase, exhibits anti- nociceptive activity in the mouse withoutincreasing blood pressure, Br.J Pharmacol., 108 (1993a) 296-297.

302. Moore, P.K., Wallace, P., Gaffen, Z., Hart, S.L. and Babbedge, R.C., Characterization of the novelnitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive andcardiovascular effects, Br.J Pharmacol., 110 (1993b) 219-224.

303. Moore, T.L., Ryan, R.E., Jr., Pohl, D.A., Roodman, S.T. and Ryan, R.E., Sr., Immunoglobulin,complement, and immune complex levels during a migraine attack, Headache, 20 (1980) 9-12.

304. Morgan, J.I. and Curran, T., Stimulus-transcription coupling in the nervous system: involvementof the inducible proto-oncogenes fos and jun, Annu.Rev.Neurosci., 14 (1991) 421-451.

305. Morgan, J.I. and Curran, T., Immediate-early genes: ten years on, Trends.Neurosci., 18 (1995)66-67.

References

137

306. Morgan, M.M., Grisel, J.E., Robbins, C.S. and Grandy, D.K., Antinociception mediated by theperiaqueductal gray is attenuated by orphanin FQ, Neuroreport, 8 (1997) 3431-3434.

307. Morrison, D.C. and Ryan, J.L., Endotoxins and disease mechanisms, Annu.Rev.Med., 38 (1987)417-432.

308. Mortimer, M.J., Kay, J., Gawkrodger, D.J., Jaron, A. and Barker, D.C., The prevalence ofheadache and migraine in atopic children: an epidemiological study in general practice,Headache, 33 (1993) 427-431.

309. Moskowitz, M.A., The neurobiology of vascular head pain, Ann.Neurol., 16 (1984) 157-168.310. Moskowitz, M.A., Basic mechanisms in vascular headache, Neurol.Clin., 8 (1990) 801-815.311. Moskowitz, M.A., Neurogenic inflammation in the pathophysiology and treatment of migraine,

Neurology, 43 (1993a) S16-20.312. Moskowitz, M.A., Nozaki, K. and Kraig, R.P., Neocortical spreading depression provokes the

expression of c- fos protein-like immunoreactivity within trigeminal nucleus caudalis viatrigeminovascular mechanisms, J.Neurosci., 13 (1993b) 1167-1177.

313. Moskowitz, M.A., Reinhard, J.F., Jr., Romero, J., Melamed, E. and Pettibone, D.J.,Neurotransmitters and the fifth cranial nerve: is there a relation to the headache phase ofmigraine?, Lancet, 2 (1979) 883-885.

314. Nakano, T., Shimomura, T., Takahashi, K. and Ikawa, S., Platelet substance P and 5-hydroxytryptamine in migraine and tension-type headache, Headache, 33 (1993) 528-532.

315. Nappi, G., Sicuteri, F., Byrne, M., Roncolato, M. and Zerbini, O., Oral sumatriptan compared withplacebo in the acute treatment of migraine, J.Neurol., 241 (1994) 138-144.

316. Nattero, G., Savi, L., Cadario, G. and Valenzano, C., Dietary migraine as adverse reactions,Cephalalgia, 9 (1989) 193-194.

317. Nelson, H.S., The Bela Schick lecture for 1985. The atopic diseases, Ann.Allergy, 55 (1985) 441-447.

318. Nicholson, K.G., Clinical features of influenza, Semin.Respir.Infect., 7 (1992) 26-37.319. Nicolodi, M. and Del Bianco, E., Sensory neuropeptides (substance P, calcitonin gene-related

peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine andcluster headache, Cephalalgia, 10 (1990) 39-50.

320. Northfield, D.W.C., Some observation on headache, Brain, 61 (1938) 133-162.321. Nozaki, K., Boccalini, P. and Moskowitz, M.A., Expression of c-fos-like immunoreactivity in

brainstem after meningeal irritation by blood in the subarachnoid space, Neuroscience, 49(1992a) 669-680.

322. Nozaki, K., Moskowitz, M.A. and Boccalini, P., CP-93,129, sumatriptan, dihydroergotamine blockc-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of themeninges, Br.J.Pharmacol., 106 (1992b) 409-415.

323. Nyholt, D.R., Dawkins, J.L., Brimage, P.J., Goadsby, P.J., Nicholson, G.A. and Griffiths, L.R.,Evidence for an X-linked genetic component in familial typical migraine, Hum.Mol.Genet., 7(1998) 459-463.

324. Oakden, E.L. and Boissonade, F.M., Fos expression in the ferret trigeminal nuclear complexfollowing tooth pulp stimulation, Neuroscience, 84 (1998) 1197-1208.

325. Ogilvie, A., Russell, M.B., Dhall, P., Battersby, S., Ulrich, V., Smith, C.A., Goodwin, G.M., Harmar,A.J. and Olesen, J., Altered allelic distributions of the serotonin transporter gene in migrainewithout aura and migraine with aura, Cephalalgia, 18 (1998) 23-26.

326. Oka, T., Aou, S. and Hori, T., Intracerebroventricular injection of interleukin-1 beta induceshyperalgesia in rats., Brain Res., 624 (1993) 61-68.

327. Olesen, J., A review of current drugs for migraine, J.Neurol., 238 Suppl 1 (1991) S23-7.328. Olesen, J., Friberg, L., Olsen, T.S., Iversen, H.K., Lassen, N.A., Andersen, A.R. and Karle, A.,

Timing and topography of cerebral blood flow, aura, and headache during migraine attacks,Ann.Neurol., 28 (1990) 791-798.

329. Olesen, J., Thomsen, L.L. and Iversen, H., Nitric oxide is a key molecule in migraine and othervascular headaches, Trends.Pharmacol.Sci., 15 (1994) 149-153.

330. Ophoff, R.A., Terwindt, G.M., Frants, R.R. and Ferrari, M.D., P/Q-type Ca2+ channel defects inmigraine, ataxia and epilepsy, Trends.Pharmacol.Sci., 19 (1998) 121-127.

References

138

331. Ophoff, R.A., Terwindt, G.M., Vergouwe, M.N., Van, E.R., Oefner, P.J., Hoffman, S.-M.G.,Lamerdin, J.E., Mohrenweiser, H.W., Bulman, D.E., Ferrari, M., Haan, J., Lindhout, D., Van-Ommen, G.-J.B., Hofker, M.H., Ferari, M.D. and Frants, R.R., Familial hemiplegic migraine andepisodic ataxia type-2 are caused by mutations in the Ca-2+ channel gene CACNL1A4., Cell, 87(1996) 543-552.

332. Ossipov, M.H., Kovelowski, C.J., Nichols, M.L., Hruby, V.J. and Porreca, F., Characterization ofsupraspinal antinociceptive actions of opioid delta agonists in the rat, Pain, 62 (1995) 287-293.

333. Pastorello, E.A., Incorvaia, C., Ortolani, C., Bonini, S., Canonica, G.W., Romagnani, S., Tursi, A.and Zanussi, C., Studies on the relationship between the level of specific IgE antibodies and theclinical expression of allergy: I. Definition of levels distinguishing patients with symptomatic frompatients with asymptomatic allergy to common aeroallergens, J Allergy Clin.Immunol., 96 (1995)580-587.

334. Pavlovic, Z.W., Cooper, M.L. and Bodnar, R.J., Opioid antagonists in the periaqueductal grayinhibit morphine and beta- endorphin analgesia elicited from the amygdala of rats, Brain Res.,741 (1996) 13-26.

335. Paxinos, G. and Watson, C. (Eds), The rat brain in stereotactic coordinates. compact thirdedition., Academic Press, San Diego, 1997.

336. Pedersen-Bjergaard, U., Nielsen, L.B., Jensen, K., Edvinsson, L., Jansen, I. and Olesen, J.,Calcitonin gene-related peptide, neurokinin A and substance P: effects on nociception andneurogenic inflammation in human skin and temporal muscle, Peptides, 12 (1991) 333-337.

337. Peitl, B., Petho, G., Porszasz, R., Nemeth, J. and Szolcsanyi, J., Capsaicin-insensitive sensory-efferent meningeal vasodilatation evoked by electrical stimulation of trigeminal nerve fibres in therat, Br.J.Pharmacol., 127 (1999) 457-467.

338. Penfield, W. and McNaughton, F., Dural headache and innervation of the dura mater,Arch.Neurol.Psychiat., 44 (1940) 43-75.

339. Perez, J., Rigo, M., Kaupmann, K., Bruns, C., Yasuda, K., Bell, G.I., Lubbert, H. and Hoyer, D.,Localization of somatostatin (SRIF) SSTR-1, SSTR-2 and SSTR-3 receptor mRNA in rat brain by insitu hybridization, Naunyn Schmiedebergs Arch Pharmacol., 349 (1994) 145-160.

340. Peroutka, S.J., Price, S.C., Wilhoit, T.L. and Jones, K.W., Comorbid migraine with aura, anxiety,and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles, Mol.Med., 4 (1998)14-21.

341. Pezeshki, G., Pohl, T. and Schobitz, B., Corticosterone controls interleukin-1 beta expression andsickness behavior in the rat, J Neuroendocrinol., 8 (1996) 129-135.

342. Pfaffenrath, V. and Scherzer, S., Analgesics and NSAIDs in the treatment of the acute migraineattack., Cephalalgia, 15 (1995) 14-20.

343. Plata, S.C., Oomura, Y. and Kai, Y., Tumor necrosis factor and interleukin-1 beta: suppression offood intake by direct action in the central nervous system, Brain Res., 448 (1988) 106-114.

344. Polley, J.S., Gaskin, P.J., Perren, M.J., Connor, H.E., Ward, P. and Beattie, D.T., The activity ofGR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascularsystem, Regul.Pept., 68 (1997) 23-29.

345. Pradalier, A., Weinman, S., Launay, J.M., Baron, J.F. and Dry, J., Total IgE, specific IgE andprick-tests against foods in common migraine--a prospective study, Cephalalgia., 3 (1983) 231-234.

346. Presley, R.W., Menetrey, D., Levine, J.D. and Basbaum, A.I., Systemic morphine suppressesnoxious stimulus-evoked Fos protein- like immunoreactivity in the rat spinal cord, J.Neurosci., 10(1990) 323-335.

347. Queiroz, D.M., Mendes, E.N., Rocha, G.A., Barbosa, A.J., Carvalho, A.S. and Cunha, M.J.,Histamine concentration of gastric mucosa in Helicobacter pylori positive and negative children,Gut, 32 (1991a) 464-466.

348. Queiroz, D.M., Mendes, E.N., Rocha, G.A., Cunha, M.J., Barbosa, A.J., Lima-GF, J. and Oliveira,C.A., Helicobacter pylori and gastric histamine concentrations, J Clin.Pathol., 44 (1991b) 612-613.

349. Raboisson, P., Bourdiol, P., Dallel, R., Clavelou, P. and Woda, A., Responses of trigeminalsubnucleus oralis nociceptive neurones to subcutaneous formalin in the rat, Neurosci.Lett., 125(1991) 179-182.

References

139

350. Raboisson, P., Dallel, R., Clavelou, P., Sessle, B.J. and Woda, A., Effects of subcutaneous formalinon the activity of trigeminal brain stem nociceptive neurones in the rat, J.Neurophysiol., 73(1995) 496-505.

351. Rapoport, A.M., Ramadan, N.M., Adelman, J.U., Mathew, N.T., Elkind, A.H., Kudrow, D.B. andEarl, N.L., Optimizing the dose of zolmitriptan (Zomig,* 311C90) for the acute treatment ofmigraine - A multicenter, double-blind, placebo- controlled, dose range-finding study, Neurology,49 (1997) 1210-1218.

352. Rasmussen, B.K., Jensen, R. and Olesen, J., Impact of headache on sickness absence andutilisation of medical services: a Danish population study, J.Epidemiol.Community.Health, 46(1992a) 443-446.

353. Rasmussen, B.K. and Olesen, J., Migraine with aura and migraine without aura: anepidemiological study, Cephalalgia, 12 (1992b) 221-228.

354. Ray, B.S. and Wolff, H.G., Experimental studies on headache. Pain-sensitive structures of thehead and their significance in headache, Arch.Surg., 41 (1940) 813-856.

355. Reichlin, S., Somatostatin, N.Engl.J Med., 309 (1983) 1495-1501.356. Reubi, J.C., Cortes, R., Maurer, R., Probst, A. and Palacios, J.M., Distribution of somatostatin

receptors in the human brain: an autoradiographic study, Neuroscience, 18 (1986) 329-346.357. Reubi, J.C. and Maurer, R., Autoradiographic mapping of somatostatin receptors in the rat central

nervous system and pituitary, Neuroscience, 15 (1985) 1183-1193.358. Rosa, L.F., Effect of adrenaline on lymphocyte metabolism and function. A mechanism involving

cAMP and hydrogen peroxide, Cell Biochem.Funct., 15 (1997) 103-112.359. Rose, F.C., The history of migraine from Mesopotamian to Medieval times, Cephalalgia, 15 Suppl

15:1-3 (1995) 1-3.360. Rosenfeld, E.A. and Rowley, A.H., Infectious intracranial complications of sinusitis, other than

meningitis, in children: 12-year review, Clin.Infect.Dis., 18 (1994) 750-754.361. Rubin, L.S. and Boyer, J., A correlative study of immunoglobulin isotype expression in common

migraine, Headache, 26 (1986) 137-141.362. Russell, M.B., Holm-Thomsen, O.E., Rishoj Nielsen, M., Cleal, A., Pilgrim, A.J. and Olesen, J., A

randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan ingeneral practice, Cephalalgia, 14 (1994) 291-296.

363. Russell, M.B., Rasmussen, B.K., Fenger, K. and Olesen, J., Migraine without aura and migrainewith aura are distinct clinical entities: A study of four hundred and eighty-four male and femalemigraineurs from the general population., Cephalalgia, 16 (1996) 239-245.

364. Russell, P.C., Wright, C.E., Barer, G.R. and Howard, P., Histamine induced pulmonaryvasodilatation in the rat: site of action and changes in chronic hypoxia, Eur.Respir.J., 7 (1994)1138-1144.

365. Saito, K., Markowitz, S. and Moskowitz, M.A., Ergot alkaloids block neurogenic extravasation indura mater: proposed action in vascular headaches, Ann.Neurol., 24 (1988) 732-737.

366. Salt, T.E., Morris, R. and Hill, R.G., Distribution of substance P-responsive and nociceptiveneurones in relation to substance P-immunoreactivity within the caudal trigeminal nucleus of therat, Brain Res., 273 (1983) 217-228.

367. Sanders, W.M., Zimmerman, A.W., Mahoney, M.A. and Ballow, M., Leucocyte histamine release inmigraine, Headache, 20 (1980) 307-310.

368. Saper, C.B., Central autonomic system.In: The rat nervous system; second edition., G. Paxinos(Ed.). San Diego, Academic Press (1995) pp. 107-135.

369. Saper, C.B. and Loewy, A.D., Efferent connections of the parabrachial nucleus in the rat, BrainRes., 197 (1980) 291-317.

370. Saper, J.S., Classification of headaches.In: Headache disorders., J.S. Saper (Ed.). Littleton, PSGInc. (1983) pp. 1-5.

371. Saria, A., Lundberg, J.M., Skofitsch, G. and Lembeck, F., Vascular protein linkage in various tissueinduced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge,Naunyn Schmiedebergs Arch Pharmacol., 324 (1983) 212-218.

372. Satoh, M., [Transmission and modulation of nociceptive information in the spinal dorsal horn],Nippon Yakurigaku Zasshi, 101 (1993) 289-298.

References

140

373. Saxena, P.R. and Den, B.M., Pharmacology of antimigraine drugs, J.Neurol., 238 Suppl 1 (1991)S28-S35.

374. Saxena, P.R. and Ferrari, M.D., From serotonin receptor classification to the antimigraine drugsumatriptan, Cephalalgia, 12 (1992) 187-196.

375. Scelsa, S.N., Lipton, R.B., Sander, H. and Herskovitz, S., Headache characteristics in hospitalizedpatients with Lyme disease, Headache, 35 (1995) 125-130.

376. Schiller, J.H., Storer, B.E., Witt, P.L., Alberti, D., Tombes, M.B., Arzoomanian, R., Proctor, R.A.,McCarthy, D., Brown, R.R., Voss, S.D. and et al, Biological and clinical effects of intravenoustumor necrosis factor-alpha administered three times weekly, Cancer Res., 51 (1991) 1651-1658.

377. Schindler, M., Humphrey, P.P., Lohrke, S. and Friau, E., Immunohistochemical localization of thesomatostatin sst2(b) receptor splice variant in the rat central nervous system, Neuroscience, 90(1999) 859-874.

378. Schmidt, M., Scheidhauer, K., Luyken, C., Voth, E., Hildebrandt, G., Klug, N. and Schicha, H.,Somatostatin receptor imaging in intracranial tumours, Eur.J Nucl.Med., 25 (1998) 675-686.

379. Schoenen, J., Deficient habituation of evoked cortical potentials in migraine: A link between brainbiology, behavior and trigeminovascular activation?, Biomedicine & Pharmacotherapy, 50 (1996)71-78.

380. Schumacher, G.A. and Wolff, H.G., Experimental studies in headache: a. contrast of histamineheadache with the headache of migraine and that associated with hypertension. b. contrast ofvascular mechanisms in preheadache and in headache phenomena of migraine,Arch.Neurol.Psychiat., 45 (1941) 199-214.

381. Seabrook, G.R., Shepheard, S.L., Williamson, D.J., Tyrer, P., Rigby, M., Cascieri, M.A., Harrison,T., Hargreaves, R.J. and Hill, R.G., L-733,060, a novel tachykinin NK-1 receptor antagonist:Effects in (Ca-2+)-i mobilisation, a cardiovascular and dural extravasation assays.,Eur.J.Pharmacol., 317 (1996) 129-135.

382. Selmaj, K., Histamine release from leucocytes in migraine, Cephalalgia, 3 (1983) 37-40.383. Selmaj, K., Histamine release from leucocytes during migraine attack, Cephalalgia, 4 (1984) 97-

100.384. Senaris, R.M., Humphrey, P.P. and Emson, P.C., Distribution of somatostatin receptors 1, 2 and 3

mRNA in rat brain and pituitary, Eur.J Neurosci., 6 (1994) 1883-1896.385. Shepheard, S.L., Williamson, D.J., Beer, M.S., Hill, R.G. and Hargreaves, R.J., Differential effects

of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation inanaesthetized rats, Neuropharmacology, 36 (1997) 525-533.

386. Shepheard, S.L., Williamson, D.J., Williams, J. and Hill, R.G., Comparison of the effects ofsumatriptan and the NK~1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats, Neuropharmacology, 34 (1995) 255-255.

387. Shi, C. and Davis, M., Pain pathways involved in fear conditioning measured with fear-potentiated startle: lesion studies, J Neurosci., 19 (1999) 420-430.

388. Shigenaga, Y., Chen, I.C., Suemune, S., Nishimori, T., Nasution, I.D., Yoshida, A., Sato, H.,Okamoto, T., Sera, M. and Hosoi, M., Oral and facial representation within the medullary andupper cervical dorsal horns in the cat, J.Comp.Neurol., 243 (1986) 388-408.

389. Shigenaga, Y., Nakatani, Z., Nishimori, T., Suemune, S., Kuroda, R. and Matano, S., The cells oforigin of cat trigeminothalamic projections: especially in the caudal medulla, Brain Res., 277(1983) 201-222.

390. Shigenaga, Y., Takabatake, M., Sugimoto, T. and Sakai, A., Neurons in marginal layer oftrigeminal nucleus caudalis projecting to ventrobasal complex (VG) and posterior nuclear group(PO) demonstrated by retrograde labeling with horseradish peroxidase, Brain Res., 166 (1979)391-396.

391. Shimomura, T., Araga, S., Esumi, E. and Takahashi, K., Decreased serum interleukin-2 level inpatients with chronic headache, Headache., 31 (1991) 310-313.

392. Shimomura, T., Araga, S., Kowa, H. and Takahashi, K., Immunoglobulin kappa/lambda ratios inmigraine and tension-type headache, Jpn.J.Psychiatry Neurol., 46 (1992) 721-726.

References

141

393. Shiraishi, T., Onoe, M., Kojima, T., Sameshima, Y. and Kageyama, T., Effects of hypothalamicparaventricular nucleus: electrical stimulation produce marked analgesia in rats,Neurobiology.(Bp.), 3 (1995) 393-403.

394. Sicuteri, F., Geppetti, P., Marabini, S. and Lembeck, F., Pain relief by somatostatin in attacks ofcluster headache, Pain, 18 (1984) 359-365.

395. Silberstein, S.D., Divalproex sodium in headache: Literature review and clinical guidelines.,Headache, 36 (1996) 547-555.

396. Silberstein, S.D., Preventive treatment of migraine: An overview, Cephalalgia, 17 (1997) 67-72.397. Simone, D.A., Baumann, T.K. and LaMotte, R.H., Dose-dependent pain and mechanical

hyperalgesia in humans after intradermal injection of capsaicin., Pain, 38 (1989) 99-107.398. Sjaastad, O., Gjesdahl, P. and Gjessing, L.R., Amino acids in urine in spontaneous migraine

attacks, Eur.Neurol., 7 (1972) 137-145.399. Sjaastad, O. and Sjaastad, O.V., The histaminuria in vascular headache, Acta Neurol.Scand., 46

(1970) 331-342.400. Sjaastad, O. and Sjaastad, O.V., Histamine metabolism in cluster headache and migraine.

Catabolism of 14C histamine, J.Neurol., 216 (1977a) 105-117.401. Sjaastad, O. and Sjaastad, O.V., Urinary histamine excretion in migraine and cluster headache.

Further observations, J.Neurol., 216 (1977b) 91-104.402. Slugg, R.M. and Light, A.R., Spinal cord and trigeminal projections to the pontine parabrachial

region in the rat as demonstrated with Phaseolus vulgaris leucoagglutinin, J Comp.Neurol., 339(1994) 49-61.

403. Sluka, K.A., Blockade of calcium channels can prevent the onset of secondary hyperalgesia andallodynia induced by intradermal injection of capsaicin in rats, Pain, 71 (1997a) 157-164.

404. Sluka, K.A. and Willis, W.D., The effects of G-protein and protein kinase inhibitors on thebehavioral responses of rats to intradermal injection of capsaicin, Pain, 71 (1997b) 165-178.

405. Smith, R.S., The cytokine theory of headache, Med.Hypotheses, 39 (1992) 168-174.406. Solomon, G.D., Cady, R.K., Klapper, J.A., Earl, N.L., Saper, J.R. and Ramadan, N.M., Clinical

efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine, Neurology, 49(1997) 1219-1225.

407. Sonnenberg, J.L., Rauscher, F.J.3., Morgan, J.I. and Curran, T., Regulation of proenkephalin byFos and Jun, Science, 246 (1989) 1622-1625.

408. Sonti, G., Flynn, M.C. and Plata, S.C., Interleukin-1 (IL-1) receptor type I mediates anorexia butnot adipsia induced by centrally administered IL-1beta, Physiol.Behav., 62 (1997) 1179-1183.

409. Spierings, E.L. and Saxena, P.R., The action of ergotamine on the distribution of carotid bloodflow--the migraine shunt theory revisited, Headache, 20 (1980) 143-145.

410. Spokes, R.A. and Middlefell, V.C., Simultaneous measurement of plasma protein extravasationand carotid vascular resistance in the rat, Eur.J.Pharmacol., 281 (1995) 75-79.

411. Spriggs, D.R., Sherman, M.L., Michie, H., Arthur, K.A., Imamura, K., Wilmore, D., Frei, E. andKufe, D.W., Recombinant human tumor necrosis factor administered as a 24-hour intravenousinfusion. A phase I and pharmacologic study, J Natl.Cancer Inst., 80 (1988) 1039-1044.

412. Stamford, J.A., Descending control of pain, Br.J Anaesth., 75 (1995) 217-227.413. Stanfa, L.C., Misra, C. and Dickenson, A.H., Amplification of spinal nociceptive transmission

depends on the generation of nitric oxide in normal and carrageenan rats, Brain Res, 737 (1996)92-98.

414. Steiger, H.J. and Meakin, C.J., The meningeal representation in the trigeminal ganglion - anexperimental study in the cat, Headache, 24 (1984) 305-309.

415. Steiger, H.J., Tew, J.M., Jr. and Keller, J.T., The sensory representation of the dura mater in thetrigeminal ganglion of the cat, Neurosci.Lett., 31 (1982) 231-236.

416. Stewart, W.F., Lipton, R.B., Celentano, D.D. and Reed, M.L., Prevalence of migraine headache inthe United States. Relation to age, income, race, and other sociodemographic factors, JAMA, 267(1992) 64-69.

417. Stewart, W.F., Shechter, A. and Lipton, R.B., Migraine heterogeneity. Disability, pain intensity,and attack frequency and duration, Neurology, 44 (1994a) S24-39.

418. Stewart, W.F., Shechter, A. and Rasmussen, B.K., Migraine prevalence. A review of population-based studies, Neurology, 44 (1994b) S17-23.

References

142

419. Storer, R.J. and Goadsby, P.J., Microiontophoretic application of serotonin (5HT)(1B/1D) agonistsinhibits trigeminal cell firing in the cat, Brain, 120 (1997) 2171-2177.

420. Storer, R.J. and Goadsby, P.J., Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors, Neuroscience, 90 (1999) 1371-1376.

421. Strassman, A.M., Mineta, Y. and Vos, B.P., Distribution of fos-like immunoreactivity in themedullary and upper cervical dorsal horn produced by stimulation of dural blood vessels in therat, J.Neurosci., 14 (1994) 3725-3735.

422. Strassman, A.M., Raymond, S.A. and Burstein, R., Sensitization of meningeal sensory neuronsand the origin of headaches., Nature, 384 (1996) 560-564.

423. Strassman, A.M. and Vos, B.P., Somatotopic and laminar organization of fos-like immunoreactivityin the medullary and upper cervical dorsal horn induced by noxious facial stimulation in the rat,J.Comp.Neurol., 331 (1993) 495-516.

424. Sugimoto, T., Fujiyoshi, Y., Xiao, C., He, Y. F., and Ichikawa, H., Central projection of calcitoningene-related peptide (CGRP)- and substance P (SP)-immunoreactive trigeminal primary neuronsin the rat, <Journal Name> 378 (1997) 425-442.

425. Sugimoto, T., He, Y.F., Xiao, C. and Ichikawa, H., c-fos induction in the subnucleus oralisfollowing trigeminal nerve stimulation, Brain Res., 783 (1998) 158-162.

426. Sutton, L.C., Grahn, R.E., Wiertelak, E.P., Watkins, L.R. and Maier, S.F., Inescapable shock-induced potentiation of morphine analgesia in rats: involvement of opioid, GABAergic, andserotonergic mechanisms in the dorsal raphe nucleus, Behav.Neurosci., 111 (1997) 816-824.

427. Suzuki, H., Zweifach, B.W. and Schmid, S.G., Vasodilator response of mesenteric arterioles tohistamine in spontaneously hypertensive rats, Hypertension, 26 (1995) 397-400.

428. Szallasi, A., Nilsson, S., Farkas, S.T., Blumberg, P.M., Hokfelt, T. and Lundberg, J.M., Vanilloid(capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord,axonal transport to the periphery, and depletion by systemic vanilloid treatment, Brain Res., 703(1995) 175-183.

429. Szolcsanyi, J., Capsaicin and nociception, Acta Physiol.Hung., 69 (1987) 323-332.430. Szolcsanyi, J., Actions of capsaicin on sensory receptors.In: Capsaicin in the study of pain., J.

Wood (Ed.). San Diego, Academic Press Limited (1993) pp. 1-26.431. Tache, Y., Rivier, J., Vale, W. and Brown, M., Is somatostatin or a somatostatin-like peptide

involved in central nervous system control of gastric secretion?, Regul.Pept., 1 (1981) 307-315.432. Takayama, K., Suzuki, T. and Miura, M., The comparison of effects of various anesthetics on

expression of Fos protein in the rat brain, Neurosci.Lett., 176 (1994) 59-62.433. Tassorelli, C. and Joseph, S.A., NADPH-diaphorase activity and Fos expression in brain nuclei

following nitroglycerin administration, Brain Res., 695 (1995a) 37-44.434. Tassorelli, C. and Joseph, S.A., Systemic nitroglycerin induces Fos immunoreactivity in brainstem

and forebrain structures of the rat, Brain Res., 682 (1995b) 167-167.435. Tassorelli, C., Joseph, S.A. and Nappi, G., Neurochemical mechanisms of nitroglycerin-induced

neuronal activation in rat brain: A pharmacological investigation, Neuropharmacology, 36 (1997)1417-1424.

436. Tataranni, P.A., Gautier, J.F., Chen, K., Uecker, A., Bandy, D., Salbe, A.D., Pratley, R.E., Lawson,M., Reiman, E.M. and Ravussin, E., Neuroanatomical correlates of hunger and satiation inhumans using positron emission tomography, Proc.Natl.Acad.Sci.U.S.A., 96 (1999) 4569-4574.

437. Ter Horst, G.J. and Streefland, C., Ascending projections of the solitary tract nucleus.In: Nucleusof the Solitary Tract., I.R.A. Barraca (Ed.). Boca Raton, CRC Press (1994) pp. 93-103.

438. Terwindt, G.M., Ophoff, R.A., Haan, J., Sandkuijl, L.A., Frants, R.R. and Ferrari, M.D., Migraine,ataxia and epilepsy: a challenging spectrum of genetically determined calcium channelopathies,Eur.J.Human.Genet., 6 (1998a) 297-307.

439. Terwindt, G.M., Ophoff, R.A., Haan, J., Vergouwe, M.N., vanEijk, R., Frants, R.R. and Ferrari,M.D., Variable clinical expression of mutations in the P/Q-type calcium channel gene in familialhemiplegic migraine, Neurology, 50 (1998b) 1105-1111.

440. Thomsen, L.L., Dixon, R., Lassen, L.H., Gibbens, M., Langemark, M., Bendtsen, L., Daugaard, D.and Olesen, J., 311C90 (Zolmitriptan), a novel centrally and peripheral acting oral 5-

References

143

hydroxytryptamine-1D agonist: A comparison of its absorption during a migraine attack and in amigraine-free period., Cephalalgia, 16 (1996) 270-275.

441. Thomsen, L.L., Iversen, H.K., Brinck, T.A. and Olesen, J., Arterial supersensitivity to nitric oxide(nitroglycerin) in migraine sufferers, Cephalalgia, 13 (1993) 395-399.

442. Thomsen, L.L. and Olesen, J., Nitric oxide theory of migraine, Clin.Neurosci., 5 (1998) 28-33.443. Thorburn, A.W. and Proietto, J., Neuropeptides, the hypothalamus and obesity: insights into the

central control of body weight, Pathology., 30 (1998) 229-236.444. Thresh, J.C., Pharm.J.Transact., 7 (1999) 259.445. Tizard, I. R. Immunology, an introduction. Fourth, international edition. 1995. Philadelphia,

Sounders college publishing.446. Totaro, R., De, M.G., Marini, C., Baldassarre, M. and Carolei, A., Sumatriptan and cerebral blood

flow velocity changes during migraine attacks, Headache, 37 (1997) 635-639.447. Tracey, D.J. and Waite, P. M. E., Somatosensory system.In: The rat nervous system; second

edition., G. Paxinos (Ed.). San Diego, Academic Press (1995) pp. 689-704.448. Traub, R.J., Silva, E., Gebhart, G.F. and Solodkin, A., Noxious colorectal distention induced-c-Fos

protein in limbic brain structures in the rat, Neurosci.Lett., 215 (1996) 165-168.449. Travagli, R.A. and Williams, J.T., Endogenous monoamines inhibit glutamate transmission in the

spinal trigeminal nucleus of the guinea-pig, J Physiol.(Lond.), 491 (1996) 177-185.450. Truesdell, L.S. and Bodnar, R.J., Reduction in cold-water swim analgesia following hypothalamic

paraventricular nucleus lesions, Physiol.Behav., 39 (1987) 727-731.451. Truog, R.D., Accurso, F.J. and Wilkening, R.B., Fetal pulmonary vasodilation by histamine:

response to H1 and H2 stimulation, Dev.Pharmacol.Ther., 14 (1990) 180-186.452. Tsai, S.H., Tew, J.M., McLean, J.H. and Shipley, M.T., Cerebral arterial innervation by nerve fibers

containing calcitonin gene-related peptide (CGRP): I. Distribution and origin of CGRP perivascularinnervation in the rat, J.Comp.Neurol., 271 (1988) 435-444.

453. Tzanc, A., Le tatrate d'ergotamine dans le traitement des migraines, Bull.et Me.de la Soc.Med.desHopitaux de Paris, I (1929) 495.

454. Uddman, R., Edvinsson, L., Ekman, R., Kingman, T. and McCulloch, J., Innervation of the felinecerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal originand co-existence with substance P, Neurosci.Lett., 62 (1985) 131-136.

455. Uehara, A., Sekiya, C., Takasugi, Y., Namiki, M. and Arimura, A., Anorexia induced by interleukin1: involvement of corticotropin-releasing factor, Am.J Physiol., 257 (1989) R613-R617.

456. Uehara, Y., Shimizu, H., Sato, N., Mura, Y.S. and Mori, M., The dipeptide Lys-Pro attenuatesinterleukin-1 beta-induced anorexia, Peptides, 14 (1993) 175-178.

457. Vahlquist, B., Migraine in Children, Int.Arch.Allergy Appl.Immunol., 7 (1955) 348-355.458. van Hilten, J.J., Ferrari, M.D., Van der Meer, J.W., Gijsman, H.J. and Looij, B.J., Jr., Plasma

interleukin-1, tumour necrosis factor and hypothalamic-pituitary-adrenal axis responses duringmigraine attacks, Cephalalgia., 11 (1991) 65-67.

459. Vanetti, M., Vogt, G. and Hollt, V., The two isoforms of the mouse somatostatin receptor(mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization, FEBS Lett., 331 (1993) 260-266.

460. Vanetti, M., Ziolkowska, B., Wang, X., Horn, G. and Hollt, V., mRNA distribution of two isoformsof somatostatin receptor 2 (mSSTR2A and mSSTR2B) in mouse brain, Brain Res.Mol.Brain Res.,27 (1994) 45-50.

461. Velasquez, R.D., Brunner, G., Varrentrapp, M., Tsikas, D. and Frolich, J.C., Helicobacter pyloriproduces histamine and spermidine, Z.Gastroenterol., 34 (1996) 116-122.

462. Vidal, C. and Jacob, J., The effect of medial hypothalamus lesions on pain control, Brain Res.,199 (1980) 89-100.

463. Vincent, S.R. and Kimura, H., Histochemical mapping of nitric oxide synthase in the rat brain,Neuroscience, 46 (1992) 755-784.

464. Visintini, D., Trabattoni, G., Manzoni, G.C., Lechi, A., Bortone, L. and Behan, P.O., Immunologicalstudies in cluster headache and migraine, Headache, 26 (1986) 398-402.

465. Visser, W.H., Ferrari, M.D., Bayliss, E.M., Ludlow, S. and Pilgrim, A.J., Treatment of migraineattacks with subcutaneous sumatriptan: first placebo-controlled study. The SubcutaneousSumatriptan International Study Group, Cephalalgia, 12 (1992) 308-313.

References

144

466. Visser, W.H., Terwindt, G.M., Reines, S.A., Jiang, K., Lines, C.R. and Ferrari, M.D., Rizatriptan vssumatriptan in the acute treatment of migraine: A placebo-controlled, dose-ranging study.,Archives of Neurology, 53 (1996) 1132-1137.

467. Volke, V., Soosaar, A., Koks, S., Bourin, M., Mannisto, P.T. and Vasar, E., 7-Nitroindazole, a nitricoxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety,Psychopharmacology (Berl.), 131 (1997) 399-405.

468. Waelkens, J., Warning symptoms in migraine: characteristics and therapeutic implications,Cephalalgia, 5 (1985) 223-228.

469. Wahlberg, P., Saikku, P. and Brummer-Korvenkontio, M., Tick-borne viral encephalitis in Finland.The clinical features of Kumlinge disease during 1959-1987, J Intern.Med., 225 (1989) 173-177.

470. Wainscott, D.B., Johnson, K.W., Phebus, L.A., Schaus, J.M. and Nelson, D.L., Human 5-HT1Freceptor-stimulated [S-35]GTP gamma S binding: correlation with inhibition of guinea pig duralplasma protein extravasation, Eur.J.Pharmacol., 352 (1998) 117-124.

471. Waite, P.M.E. and Tracey, D. J., Trigeminal sensory system.In: The rat nervous system; secondedition., G. Paxinos (Ed.). San Diego, Academic Press (1995) pp. 705-724.

472. Wang, L.G., Li, H.M. and Li, J.S., Formalin induced FOS-like immunoreactive neurons in thetrigeminal spinal caudal subnucleus project to contralateral parabrachial nucleus in the rat, BrainRes., 649 (1994) 62-70.

473. Wang, W. and Schoenen, J., Interictal potentiation of passive ''oddball'' auditory event-relatedpotentials in migraine, Cephalalgia., 18 (1998) 261-265.

474. Wang, W., Timsit Berthier, M. and Schoenen, J., Intensity dependence of auditory evokedpotentials is pronounced in migraine: an indication of cortical potentiation and low serotonergicneurotransmission?, Neurology, 46 (1996) 1404-1409.

475. Watkins, L.R., Wiertelak, E.P., Goehler, L.E., Mooney, H.K., Martinez, J., Furness, L., Smith, K.P.and Maier, S.F., Neurocircuitry of illness-induced hyperalgesia., Brain Res, 639 (1994a) 283-299.

476. Watkins, L.R., Wiertelak, E.P., Goehler, L.E., Smith, K.P., Martin, D. and Maier, S.F.,Characterization of cytokine-induced hyperalgesia., Brain Res, 654 (1994b) 15-26.

477. Wei, E.P., Moskowitz, M.A., Boccalini, P. and Kontos, H.A., Calcitonin gene-related peptidemediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles,Circ.Res., 70 (1992) 1313-1319.

478. Weiller, C., May, A., Limmroth, V., Juptner, M., Kaube, H., Schayck, R.V., Coenen, H.H. andDiener, H.C., Brain stem activation in spontaneous human migraine attacks, Nat.Med., 1 (1995)658-660.

479. Welch, K.M., Barkley, G.L., Tepley, N. and Ramadan, N.M., Central neurogenic mechanisms ofmigraine, Neurology, 43 (1993) S21-5.

480. Welker, C., Microelectrode delineation of fine grain somatotopic organization of (SmI) cerebralneocortex in albino rat, Brain Res., 26 (1971) 259-275.

481. Werka, T., The effects of the medial and cortical amygdala lesions on post-stress analgesia inrats, Behav.Brain Res., 86 (1997) 59-65.

482. Westlund, K.N., Zhang, D., Carlton, S.M., Sorkin, L.S. and Willis, W.D., Noradrenergic innervationof somatosensory thalamus and spinal cord, Prog.Brain Res., 88 (1991) 77-88.

483. Wheeler Aceto, H., Porreca, F. and Cowan, A., The rat paw formalin test: comparison of noxiousagents, Pain, 40 (1990) 229-238.

484. Williamson, D.J., Hargreaves, R.J., Hill, R.G. and Shepheard, S.L., Sumatriptan inhibitsneurogenic vasodilation of dural blood vessels in the anaesthetized rat - Intravital microscopestudies, Cephalalgia, 17 (1997a) 525-531.

485. Williamson, D.J., Shepheard, S.L., Hill, R.G. and Hargreaves, R.J., The novel anti-migraine agentrizatriptan inhibits neurogenic dural vasodilation and extravasation, Eur.J Pharmacol., 328(1997b) 61-64.

486. Worrall, N.K., Chang, K., LeJeune, W.S., Misko, T.P., Sullivan, P.M., Ferguson-TB, J. andWilliamson, J.R., TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction viaNO-dependent and -independent mechanisms, Am.J Physiol., 273 (1997) H2565-H2574.

487. Wu, J., Lin, Q., McAdoo, D.J. and Willis, W.D., Nitric oxide contributes to central sensitizationfollowing intradermal injection of capsaicin, Neuroreport., 9 (1998) 589-592.

References

145

488. Yamamura, H., Malick, A., Chamberlin, N.L. and Burstein, R., Cardiovascular and neuronalresponses to head stimulation reflect central sensitization and cutaneous allodynia in a rat modelof migraine, J.Neurophysiol., 81 (1999) 479-493.

489. Yamashiro, T., Satoh, K., Nakagawa, K., Moriyama, H., Yagi, T. and Takada, K., Expression ofFos in the rat forebrain following experimental tooth movement, J Dent.Res., 77 (1998) 1920-1925.

490. Yano, H., Wershil, B.K., Arizono, N. and Galli, S.J., Substance P-induced augmentation ofcutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent, JClin.Invest., 84 (1989) 1276-1286.

491. Yasui, Y., Breder, C.D., Saper, C.B. and Cechetto, D.F., Autonomic responses and efferentpathways from the insular cortex in the rat, J Comp.Neurol., 303 (1991) 355-374.

492. Yin, K.J., Distribution of somatostatin mRNA containing neurons in the primary pain relayingnuclei of the rat, Anat.Rec., 241 (1995) 579-584.

493. Yirmiya, R., Ben-Eliyahu, S., Shavit, Y., Marek, P. and Liebeskind, J.C., Stimulation of thehypothalamic paraventricular nucleus produces analgesia not mediated by vasopressin orendogenous opioids, Brain Res., 537 (1990) 169-174.

494. Yirmiya, R., Rosen, H., Donchin, O. and Ovadia, H., Behavioral effects of lipopolysaccharide inrats: involvement of endogenous opioids, Brain Res., 648 (1994) 80-86.

495. Yokota, T., Koyama, N. and Matsumoto, N., Somatotopic distribution of trigeminal nociceptiveneurons in ventrobasal complex of cat thalamus, J Neurophysiol., 53 (1985) 1387-1400.

496. Yoshikawa, T.T. and Quinn, W., The aching head. Intracranial suppuration due to head and neckinfections, Infect.Dis.Clin.North Am., 2 (1988) 265-277.

497. Yu, X.J., Cutrer, F.M., Moskowitz, M.A. and Waeber, C., The 5-HT1D receptor antagonist GR-127,935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenicplasma extravasation within guinea pig dura mater, Neuropharmacology, 36 (1997) 83-91.

498. Zagami, A.S., 311C90: Long-term efficacy and tolerability profile for the acute treatment ofmigraine, Neurology, 48 (1997) S25-S28.

499. Zagami, A.S., Goadsby, P.J. and Edvinsson, L., Stimulation of the superior sagittal sinus in the catcauses release of vasoactive peptides, Neuropeptides, 16 (1990a) 69-75.

500. Zagami, A.S. and Lambert, G.A., Stimulation of cranial vessels excites nociceptive neurones inseveral thalamic nuclei of the cat, Exp.Brain Res., 81 (1990b) 552-566.

501. Zeisberger, E. and Bruck, K., Alteration of shivering threshold in cold- and warm-adapted guineapigs following intrahypothalamic injections of noradrenaline and of an adrenergic alpha-receptorblocking agent, Pflugers Arch, 362 (1976) 113-119.

502. Zhang, C., Yang, S.W., Guo, Y.G., Qiao, J.T. and Dafny, N., Locus coeruleus stimulationmodulates the nociceptive response in parafascicular neurons: An analysis of descending andascending pathways, Brain Res Bull., 42 (1997) 273-278.

503. Zimmermann, M., Ethical guidelines for investigations of experimental pain in conscious animals[editorial], Pain, 16 (1983) 109-110.

504. Zwetsloot, C.P., Caekebeke, J.F. and Ferrari, M.D., Lack of asymmetry of middle cerebral arteryblood velocity in unilateral migraine, Stroke, 24 (1993) 1335-1338.

505. Zwetsloot, C.P., Caekebeke, J.F., Jansen, J.C., Odink, J. and Ferrari, M.D., Blood flow velocitychanges in migraine attacks--a transcranial Doppler study, Cephalalgia., 11 (1991a) 103-107.

506. Zwetsloot, C.P., Caekebeke, J.F., Odink, J. and Ferrari, M.D., Vascular reactivity during migraineattacks: a transcranial Doppler study, Headache, 31 (1991b) 593-595

146